Micro-Fluidic Device And Uses Thereof
A micro-fluidic device includes at least one inlet and a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having a) the radially inner side and the radially outer side unequal in height, or b) the radially inner side equal in height to the radially outer side, and wherein the top side has at least two continuous straight sections, each unequal in width to the bottom side.
This application claims the benefit of U.S. Provisional Application No. 61/704,128, filed on Sep. 21, 2012. The entire teachings of this application are incorporated herein by reference.GOVERNMENT SUPPORT
This invention was made with government support under Grant No. N66001-11-1-4182 awarded by the Space and Naval Warfare Systems Command. The government has certain rights in this invention.BACKGROUND OF THE INVENTION
Conventional macroscale methods for separation of cells include physical filtration using membrane-based filter and density gradient centrifugation which exploit differences in cell size, deformability, and density to filter out target cells. These techniques are labor-intensive and require multi-step sample preparations which may introduce artifacts or lead to loss of desired cells. Membrane filtration methods are also easily susceptible to clogging and require frequent cleaning. Further, evidence of mechanical stress-induced changes in original phenotype of target cells subjected to filtration and centrifugation techniques has also been reported. Recently, inertial micro-fluidic devices were explored as a filterless size-based cell fractionation method. See Di Carlo D. Inertial microfluidics. Lab on a chip. 2009; 9(21):3038-46; Kuntaegowdanahalli S S, et al. Lab on a chip. 2009; 9(20):2973-80; Bhagat A A S, et al. Biomedical Microdevices. 2010; 12(2):187-95.
However, there is a continuing need to develop simpler and more efficient techniques to process blood samples that can minimize cell loss and maintain the original target cell phenotype for subsequent analysis.SUMMARY OF THE INVENTION
The, invention is generally directed to micro-fluidic devices having curved micro-channels with non-rectangular cross sections for particle focusing and mixing. In a particular aspect, the invention is directed to a micro-fluidic device that includes at least one inlet and a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having a) the radially inner side and the radially outer side unequal in height, or b) the radially inner side equal in height to the radially outer side, and wherein the top side has at least two continuous straight sections, each unequal in width to the bottom side. The micro-fluidic device further includes at least one outlet. In certain aspects, the micro-fluidic device includes two outlets. In some aspects, the micro-fluidic device includes a single inlet.
In some aspects, the cross section of the micro-fluidic device can have (a) the height of the radially inner side larger than the height of the radially outer side, or (b) the height of the radially inner side smaller than the height of the radially outer side, or (c) the top side including at least one step forming a stepped profile, or (d) the top side including at least one shallow region in between the radially inner side and the radially outer side. The trapezoidal cross section can be a right trapezoidal cross section. In certain aspects, the top and/or bottom sides of the trapezoidal cross section can be curved, with a curvature that can be convex or concave.
In other aspects, the radially inner side and the radially outer side of the trapezoidal cross section can have a height in a range of between about 20 microns (μm) and about 200 μm. In certain aspects, the top side and the bottom side of the trapezoidal cross section can have a width in a range of between about 100 μm and about 2000 μm.
In one aspect, the curvilinear microchannel can be a spiral microchannel. In another aspect, the curvilinear microchannel can be a serpentine microchannel. The curvilinear microchannel can have a radius of curvature in a range of between about 2.5 mm and about 25 mm, and a length in a range of between about 4 cm and about 100 cm.
In yet another aspect, the invention is directed to a method of separating by size one or more particles from a mixture of particles. The method comprises introducing the mixture into at least one inlet of a micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having the height of the radially inner side smaller than the height of the radially outer side, at a flow rate that isolates particles along portions of the cross-section of the microchannel based on particle size, wherein larger particles flow along the radially inner side of the microchannel to a first outlet and smaller particles flow along other portions of the microchannel to at least one other outlet, thereby size separating the particles from the mixture. The method can include collecting size separated particles from the first outlet. In one aspect, the flow rate can be in a range of between about 0.5 mL/min and about 7.5 mL/min. In some aspects, the particles can be cells, such as stem cells.
In a particular aspect, the flow rate can be about 2.5 mL/min, the larger particles can have a diameter in a range of between about 18 μm and about 40 μm, and the smaller particles can have a diameter in a range of between about 10 μm and about 20 μm. In another particular aspect, the flow rate can be about 1.5 mL/min, the larger particles can have an diameter in a range of between about 15 μm and about 25 μm, and the smaller particles can have a diameter in a range of between about 5 μm and about 10 μm. In still another particular aspect, the flow rate can be in a range of between about 2.5 mL/min and about 3.0 mL/min, the larger particles can have a diameter in a range of between about 25 μm and about 40 μm, and the smaller particles can have a diameter in a range of between about 5 μm and about 15 μm.
In another aspect, the mixture of cells can be a blood sample, and the larger cells can be circulating tumor cells (CTCs), and the smaller cells can be hematologic cells. In one aspect, he flow rate can be adapted to size separate about 7.5 mL of blood in about 8 minutes. In still another aspect, the larger cells can be leukocytes, and the smaller cells can be hematologic cells. In yet another aspect, the mixture can be a bone marrow sample, wherein stem cells can be separated from hematologic cells.
In still another aspect, the invention is directed to a method of concentrating cells from a mixture. The method comprises introducing the mixture into at least one inlet of a micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having the height of the radially inner side larger than the height of the radially outer side, at a flow rate that isolates the cells along the radially inner side of the cross section of the microchannel and directs them to a first outlet, thereby concentrating the cells from the mixture. The method can include collecting concentrated cells from the first outlet. In particular aspects, the flow rate can be in a range of between about 0.5 mL/min and about 10 mL/min.
In yet another aspect, the invention is directed to a method of filtering particulates from a mixture. The method comprises introducing a particulate containing mixture into at least one inlet of a micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having the height of the radially inner side larger than the height of the radially outer side, at a flow rate that isolates particulates along the radially inner side of the cross section of the microchannel and directs them to a first outlet, thereby filtering the particulates from the mixture. In some aspects, the mixture can be water. The method can include collecting particulates from, the first outlet. In particular aspects, the flow rate can be in a range of between about 0.5 mL/min and about 10 mL/min.
In another aspect, the invention is directed to a method of distributing cells in a mixture. The method comprises introducing the mixture into at least one inlet of the micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having the top side that includes at least one step forming a stepped profile, at a flow rate that distributes cells along portions of the stepped profile, wherein cells do not impact the sides before, during, or after distribution to separate outlets, thereby distributing the cells in the mixture. The method can include collecting distributed cells from the separate outlets. In particular aspects, the flow rate can be in a range of between about 2 mL/min and about 10 mL/min.
In yet another aspect, the invention is directed to a method of mixing cells in a liquid. The method comprises introducing a liquid and cells into at least one inlet of the micro-fluidic device having a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having the top side including at least one shallow region in between the radially inner side and the radially outer side, at a flow rate that mixes cells along the microchannel and directs the mixture to a first outlet. The method can include collecting the mixture from the first outlet. In particular aspects, the flow rate can be in a range of between about 0.1 mL/min and about 2 mL/min.
This invention has many advantages, including higher resolution separation than could be obtained with present micro-fluidic devices. The magnitude of the channel dimensions are normally >3 times the particle diameter, which not only makes the device free of clogging issues and high throughput, but also reduce the cost of fabrication. These advantages suggest a broad range of applications of curved micro-fluidic device in the future. Moreover, with the variation of channel shape, the invention described here offers many distinct advantages over traditional rectangular curved micro-channels. In particular for the application of high resolution particle separation, particles are separated into two main streams along the inner and outer side according to their diameter and the flow rate. This type of device is able to achieve high resolution, high throughput separation, which is not feasible with traditional rectangular channels.
The foregoing will be apparent from the following more particular description of example embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments of the present invention.
A description of example embodiments of the invention follows.
In micro-fluidic devices, particles flowing in curvilinear channels are influenced by both inertial migration and secondary Dean flows. The combination of Dean flow and inertial lift results in focusing and positioning of particles at distinct positions for concentration and separation applications.
Described herein is a set of curved micro-channels with non-rectangular cross-sections which are introduced into a microfluidic device resulting in the alteration of the shapes and positions of the Dean vortices which generates new focusing positions for particles. For example, as shown herein, a curved micro-channel with a deeper inner side (along the curvature center) and a shallow outer side generates two strong Dean vortex cores near the inner wall, trapping all particles irrespective of size within the vortex. Such a channel finds vast applications in particle and cell concentration applications, such as water filtration and purification at ultra-high throughputs.
Ultra-high throughput is a flow rate in a range of between about 0.5 mL/min and about 1 L/min. Ultra-high throughput can be achieved by combining multiple channels in a variety of combinations. In some aspects, multiple channels can be combined into a single micro-fluidic device. In other aspects, multiple channels can be combined into a multiplexed micro-fluidic device. Thus, an ultra-high throughput flow rate can be about 0.5 mL/min, about 5 mL/min, about 10 mL/min, about 20 mL/min, about 40 mL/min, about 50 mL/min, about 100 mL/min, about 200 mL/min, about 300 mL/min, about 400 mL/min, about 500 mL/min, about 600 mL/min, about 700 mL/min, about 800 mL/min, about 900 mL/min, or about 1 L/min.
As also shown herein, if the curved micro-channel has a shallow inner side and a deeper outer side, the vortex centers are skewed near the outer wall at the outer side which entrains particles and cells within the vortex. However, larger particles with dominant inertial force are focused near the inner channel walls, similar to rectangular cross-section channels. Thus, shown herein is that by designing appropriate channel parameters, small particles/cells are trapped in the vortex at the outside, while relatively large particles focus along the inner microchannel wall. The threshold diameter determining whether a particle/cell is trapped within the Dean vortex or focused towards the inner channel wall is dependent on the flow rate. This enables such a device to achieve good separation resolution between mixtures having a wide range of particle sizes. In aspects in which only two outlets are used for collection, the throughput is much higher than in rectangular channels where the particles are focusing near the inner side of the channel, toward the outlet collection branches placed at the inner side. This leads to low separation resolution, as well as carrying high risks of channel clogging. As shown herein, with a trapezoidal cross-section, higher particle/cell concentrations can be processed, with minimal interaction between them to achieve ultra-high throughputs.
The device described herein demonstrates separation of polynuclear leukocytes (PNLs) (diameters in a range of between about 10 μm and about 15 μm) from red blood cells (RBCs) (diameters of about 7-8 μm), and small mesenchymal stem cells (MSCs) (diameters in a range of between about 14 μm and about 20 μm) from large MSCs, (diameters larger than about 20 μm) and shows that the device achieved good separation resolution and high throughput for use, e.g., in clinical analysis and cell study. Moreover, as shown herein, channels with stepped cross-section and sandwiched shallow regions can be used for particle trapping and mixing.
Several types of curved channel (spiral, serpentine, arc) have been introduced in micro-fluidics recently. Experiments have shown that particles flowing in curved channels are influenced by both inertial force and Dean flow. The balance of these two effects can provide precise focusing and positioning of particles. This phenomenon can be used in many applications such as concentration or size selective separation of particles, or liquid filtration.
Fluid flowing through a channel with a laminar profile has a maximum velocity component near the centroid of the cross section of the channel, decreasing to zero near the wall surface. In a curved channel, the fluid experiences centrifugal acceleration directed radially outward. Since the magnitude of the acceleration is proportional to quadratic velocity, the centrifugal force in the centroid of the channel cross section is higher than at the channel walls. The non-uniform centrifugal force leads to the formation of two counter-rotating vortices known as Dean vortices in the top and bottom halves of the channel, which have a radially outward flow in the center and two inward flows near the channel walls as shown in
Apart from the Dean drag force, larger cells with diameters comparable to the micro-channel dimensions also experience appreciable inertial lift forces resulting in their focusing and equilibration along the channel walls. In micro-channels with curvilinear geometry, the interplay between the inertial lift force and the Dean drag force reduces the equilibrium positions to just two near the inner channel wall at low flow rate, and move outward with an increase in flow rate, each within the top and bottom Dean vortex. The two equilibrium positions overlay each other along the micro-channel height and are located at the same distance from the micro-channel inner wall for a given cell size, i.e. viewed as a single position across the micro-channel width.
As described herein, spiral microchannels with trapezoidal cross sections have been tested. These channels are different from rectangular cross section, in that the maximum velocity is asymmetric along the channel cross-section resulting in the formation of stronger Dean vortex cores skewed towards the deeper channel side. These vortex cores have high probability to entrain particles within them. As shown herein, in a spiral channel with trapezoidal cross-section, the particle focusing behavior is different from that in a rectangular channel. In a trapezoidal channel, as shown in
Along the depth direction, according to experimental measurements, particles are focused between about 25.5-27.1% of the channel depth at flow rates of about 0.5-3.0 mL/min. This result indicates that the distance between the focused particle and the channel wall in a trapezoidal channel in the depth direction is larger than that in the rectangular channel.
If the inner wall of the channel is deeper, then these strong Dean vortices will appear at the inner side, i.e. particles will be trapped near the inner side, even at high flow rates. Curved channels with this cross section can be used to collect a larger size range of particles at the inner side of the outlet and filtered particle free liquid at the outer side of the outlet, finding numerous applications in water filtration, for example. On the other hand, if the outer wall of the channel is deeper, Dean vortices are skewed towards the outer side. At the inner side, the Dean flow field is much like that in a rectangular channel. At certain flow rates, the larger particle can focus along the inner wall influenced by both Dean flow and inertial lift, while the smaller particles tend to get trapped in the vortex center at the outer side. The different type of particle positioning (inside or outside) relative to their diameter presents a new size selective separation process.
Accordingly, in some aspects, the invention relates to a set of curved micro-channels with non-rectangular cross-section that give rise to unique Dean vortices for varying applications in micro-fluidic field relating to particle focusing, separation, and mixing. In a particular aspect, the invention is directed to a micro-fluidic device that includes at least one inlet and a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having a) the radially inner side and the radially outer side unequal in height, or b) the radially inner side equal in height to the radially outer side, and wherein the top side has at least two continuous straight sections, each unequal in width to the bottom side. The device further comprises at least one outlet. In certain aspects, a spiral channel with a trapezoidal cross-sections consisting of a shallow inner side and deeper outer wall is used as a high resolution size based particle separator.
In some aspects, the micro-fluidic device includes a single inlet, 2 inlets, 3 inlets, 4 inlets, 5 inlets, 6 inlets, 7 inlets, 8 inlets, 9 inlets, or 10 or more inlets.
In one aspect, the curvilinear microchannel 120 can be a spiral microchannel as shown in
The micro-fluidic device further includes at least one outlet. In certain aspects, the micro-fluidic device includes two outlets, 3 outlets, 4 outlets, 5 outlets, 6 outlets, 7 outlets, 8 outlets, 9 outlets, or 10 or more outlets. In a particular aspect, the micro-fluidic device has two outlets for waste and particle collection, respectively. In another aspect, the micro-fluidic device has a single inlet and only 2 outlets.
For a trapezoidal cross-section spiral microchannel, there are several factors that affect the focusing position and separation efficiency, such as the width of the microchannel, inner and outer depth of the microchannel cross-section, the radius of the spiral curvature, and the slant angle. The width can be in a range of between about 100 μm and about 2000 μm, such as a width of about 200 μm, about 300 μm, about 400 μm, about 500 μm, about 600 μm, about 700 μm, about 800 μm, about 900 μm, about 1000 μm, about 1100 μm, about 1200 μm, about 1300 μm, about 1400 μm, about 1500 μm, about 1600 μm, about 1700 μm, about 1800 μm, or about 1900 μm.
The outer depth can be in a range of between about 20 μm and about 200 μm, such as an outer depth of about 40 μm, about 60 μm, about 80 μm, about 100 μm, about 120 μm, about 140 μm, about 160 μm, or about 180 μm. The inner depth can be in a range of between about 20 μm and about 200 μm, such as an inner depth of about 40 μm, about 60 μm, about 80 μm, about 100 μm, about 120 μm, about 140 μm, about 160 μm, or about 180 μm. The radius of curvature can be in a range of between about 2.5 mm and about 25 mm, such as a radius of about 5 mm, about 7.5 mm, about 10 mm, about 12.5 mm, about 15 mm, about 17.5 mm, about 20 mm, or about 22.5 mm.
The slant angle is the angle between the top of the channel and the bottom of the channel. The slant angle can be in a range of between about 2 degrees and about 60 degrees. Thus, the slant angle can be about 2 degrees, about 4 degrees, about 6 degrees, about 8 degrees, about 10 degrees, about 12 degrees, about 14 degrees, about 16 degrees, about 18 degrees, about 20 degrees, about 22 degrees, about 24 degrees, about 26 degrees, about 28 degrees, about 30 degrees, about 32 degrees, about 34 degrees, about 36 degrees, about 38 degrees, about 40 degrees, about 42 degrees, about 42 degrees, about 46 degrees, about 48 degrees, about 50 degrees, about 52 degrees, about 54 degrees, about 56 degrees, about 58 degrees, or about 60 degrees. The slant angle of the channel affects the focusing behavior in two ways: (i) the threshold flow rate required to trap particles in the Dean vortex as a function of particle size and (ii) the location of the Dean vortex core. A large slant angle (i.e., in a range of between about 10 degrees and about 60 degrees) will lead to strong Dean at the outer side and increase the particle trapping capability. A large slant angle can also decrease the threshold flow rate required to trap particles of a given size within the Dean vortex.
In a particular aspect, the invention is directed to a micro-fluidic device 100 as shown in
In some aspects, the cross section 201 of the micro-fluidic device can have the height of the radially inner side 210 larger than the height of the radially outer side 220 as shown in
In other aspects, the radially inner side 210 and the radially outer side 220 of the trapezoidal cross section can have a height in a range of between about 20 microns (μm) and about 200 μm. Thus, the height of the radially inner side 210 can be about 20 μm, about 40 μm, about 60 μm, about 80 μm, about 100 μm, about 120 μm, about 140 μm, about 160 μm, about 180 μm, or about 200 μm, and the height of the radially outer side 220 can be about 20 μm, about 40 μm, about 60 μm, about 80 μm, about 100 μm, about 120 μm, about 140 μm, about 160 μm, about 180 μm, or about 200 μm. In some aspects, the height of the radially inner side 210 can be about 70 μm, or about 80 μm, or about 90 μm, and the height of the radially outer side 220 can be about 100 μm, or about 120 μm, or about 130 μm, or about 140 μm.
In certain aspects, the top side 240 and the bottom side 230 of the trapezoidal cross section can have a width in a range of between about 100 μm and about 2000 μm, such as a width of about 200 μm, about 300 μm, about 400 μm, about 500 μm, about 600 μm, about 700 μm, about 800 μm, about 900 μm, about 1000 μm, about 1100 μm, about 1200 μm, about 1300 μm, about 1400 μm, about 1500 μm, about 1600 μm, about 1700 μm, about 1800 μm, or a width of about 1900 μm.
Thus, as described herein, spiral microchannels can comprise one or more loops. In certain aspects, the multi-loop microchannel can be a 2 loop microchannel, a 3 loop microchannel, a 4 loop microchannel a 5 loop microchannel, a 6 loop microchannel, a 7 loop microchannel, an 8 loop microchannel, a 9 loop microchannel, a 10 loop microchannel, etc. In a particular aspect, shown in
The experimental results indicate that particles occupied an equilibrium position near the inner microchannel wall when particles were introduced under a lower flow rate. However, beyond a threshold flow rate (which is dependent on the particle size) the equilibrium position was moved to the outer microchannel wall, suggested to be a Dean vortex trap. Taking advantage of this sudden transition, the trapezoidal cross-section spiral microchannel produced higher resolution separation of particles than conventional rectangular cross-section spiral. Separation of 15.5 μm and 18.68 μm beads at an ultra-high throughput of about 1.61×107/min with over 92% efficiency was achieved with this device. Ultra-high throughput can be a throughput in a range of between about 1 particles/min to about 1×109 particles/min.
As will be appreciated by those of skill in the art, depending upon the use, one or more micro-fluidic devices can be coupled, thereby generating a multiplexed device, For example, the outlet of one micro-fluidic device can be connected to the inlet of one or more micro-fluidic devices. Alternatively or additionally, multiple channels can be integrated into a micro-fluidic device. The number of channels that can be multiplexed and/or integrated into a micro-fluidic device can be in a range of between about 2 channels and about 500 channels. Thus, the number of channels can be about 2 channels, about 5 channels, about 10 channels, about 20 channels, about 30 channels, about 40 channels, about 50 channels, about 100 channels, about 200 channels, about 300 channels, about 400 channels, or about 500 channels.
As will also be appreciated by those of skill in the art, the micro-fluidic device can further comprise other components upstream, downstream, or within (e.g., a multiplexed) a device. For example, one or more micro-fluidic devices can further comprise one or more collection devices (e.g., a reservoir), flow devices (e.g., a syringe, pump, pressure gauge, temperature gauge), analysis devices (e.g., a 96-well microtiter plate, a microscope), filtration devices (e.g., a membrane), e.g., for upstream or downstream analysis (e.g., immunostaining, polymerase chain reaction (PCR) such as reverse PCR, quantitative PCR), fluorescence (e.g., fluorescence in situ hybridization (FISH)), sequencing, and the like. An imaging system may be connected to the device, to capture images from the device, and/or may receive light from the device, in order to permit real time visualization of the isolation process and/or to permit real time enumeration of isolated cells. In one example, the imaging system may view and/or digitize the image obtained through a microscope when the device is mounted on a microscope slide. For instance, the imaging system may include a digitizer and/or camera coupled to the microscope and to a viewing monitor and computer processor.
The microfluidic device described herein can be used for a variety of purposes. In one aspect, shown in
Particles present in a variety of mixtures can be introduced into the device. Examples of mixtures include biological fluids (e.g., a biological sample such as blood, lymph, urine, and the like), liquids (e.g., water), culture media, emulsions, sewage, etc. In the aspect in which the biological sample is whole blood, the blood can be introduced unadulterated or adulterated (e.g., lysed, diluted). Methods of lysing blood are known in the art. In some aspects, the volume to volume concentration of the particles as compared to other cells can be less than about 5%. Thus, the volume to volume concentration can be about 4%, about 3%, or about 2%. In some aspects, dilution of blood sample can be to a hematocrit in a range of between about 0.5% and about 2%. Thus, the hematocrit of a diluted blood sample can be about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1.0%, about 1.1%, about 1.2%, about 1.3%, about 1.4%, about 1.5%, about 1.6%, about 1.7%, about 1.8%, about 1.9%, or about 2%.
In yet another aspect, the invention is directed to a method of concentrating cells from a mixture. The method comprises introducing the mixture into at least one inlet of a micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section 201 as shown in
In yet another aspect, the invention is directed to a method of filtering particulates from a mixuture (e.g., water). Particulates can include bacteria, fungi, parasites, floc, or other sedimentary aggregates present in water. The method comprises introducing particulate containing water into at least one inlet of a micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section 201 as shown in
In another aspect, the invention is directed to a method of distributing cells in a mixture. The method comprises introducing the mixture into at least one inlet of the micro-fluidic device that includes a curvilinear microchannel having a trapezoidal cross section 203 as shown in
In yet another aspect, a method of mixing cells in a liquid includes introducing a liquid and cells into at least one inlet of the micro-fluidic device having a curvilinear microchannel having a trapezoidal cross section 204 as shown in
In the methods described herein, fluid can be introduced into the micro-fluidic device in a variety of ways. In one aspect, fluid can be introduced into the micro-fluidic device using a syringe pump. In other aspects, fluid can be introduced into the micro-fluidic device using a piston pump, a gear pump, a peristaltic pump, a piezoelectric micropump, or using a controllable pressure regulator. The flow rate of fluid through the micro-fluidic device will vary depending on the use. In some aspects, the flow rate can be in a range of between about 0.5 mL/min and about 10 mL/min, such as a flow rate of about 1 mL/min, about 2 mL/min, about 3 mL/min, about 4 mL/min, about 5 mL/min, about 6 mL/min, about 7 mL/min, about 8 mL/min, or about 9 mL/min.
A variety of particles can be separated using the micro-fluidic device. In a particular aspect, larger particles can be separated from smaller particles. Larger particles can have a diameter from about 18 μm to about 50 μm. For example, larger particles can have a diameter of about 19 μm, about 20 μm, about 21 μm, about 22 μm, about 23 μm, about 24 μm, about 25 μm, about 26 μm, about 27 μm, about 28 μm, about 29 μm, about 30 μm, about 31 μm, about 32 μm, about 33 μm, about 34 μm, about 35 μm, about 36 μm, about 37 μm, about 38 μm, about 39 μm, about 40 μm, about 41 μm, about 42 μm, about 43 μm, about 44 μm, about 45 μm, about 46 μm, about 47 μm, about 48 μm, about 49 μm, or about 50 μm. Smaller particles can have a diameter from about 2 μm to about 14 μm. For example, smaller particles can have a diameter of about 2 μm, about 3 μm, about 4 μm, about 5 μm, about 6 μm, about 7 μm, about 8 μm, about 9 μm, about 10 μm, about 11 μm, about 12 μm, about 13 μm, or about 14 μm. In a particular aspect, the flow rate can be about 2.5 mL/min, the larger particles can have a diameter in a range of between about 18 μm and about 40 μm, and the smaller particles can have a diameter in a range of between about 10 μm and about 20 μm. In another particular aspect, the flow rate can be about 1.5 mL/min, the larger particles can have an diameter in a range of between about 15 μm and about 25 μm, and the smaller particles can have a diameter in a range of between about 5 μm and about 10 μm. In still another particular aspect, the flow rate can be in a range of between about 2.5 mL/min and about 3.0 mL/min, the larger particles can have a diameter in a range of between about 25 μm and about 40 μm, and the smaller particles can have a diameter in a range of between about 5 μm and about 15 μm.
In some aspects, the particles can be cells, such as stem cells. In another aspect, the cells can be present in a biological fluid (e.g., blood, urine, lymph, cerebrospinal fluid, and the like). In a particular aspect, the cells are present in a blood sample, wherein the larger cells are circulating tumor cells (CTCs), and the smaller cells are hematologic cells. In some aspects, the CTCs are cancer cells (e.g., metastatic cancer cells) from a (one or more) breast cancer, colorectal cancer, kidney cancer, lung cancer, gastric cancer, prostate cancer, ovarian cancer, squamous cell cancer, hepatocellular cancer, nasopharyngeal cancer and other types of cancer cells. Because this approach does not require initial cell surface biomarker selection, it is suitable for use in different cancers of both epithelial and non-epithelial origin.
The methods described herein can further comprise collecting and isolating the separated particles (e.g., cells). In certain aspects, the method can further comprise downstream analysis such as immunostaining, qRT-PCR, FISH and sequencing. In a particular aspect, the method can further comprise conducting a heterogeneity study.
In the methods described herein, unless otherwise specified, the capture efficiency of particles (e.g., CTCs) can be in a range of between about 60% and about 100%, such as about 62%, about 64%, about 66%, about 68%, about 70%, about 72%, about 74%, about 76%, about 78%, about 80%, about 82%, about 84%, about 86%, about 88%, about 90%, about 92%, about 94%, about 96%, about 98%, and about 99%. In a particular aspect, the capture efficiency can be an average recovery of 80%, or 85%, or 87%. In another particular aspect, detection of HER2 amplification in CTCs can identify high-risk breast cancer patients who may benefit from HER2 associated therapeutic strategies.
The micro-fluidic device described herein can process milliliter quantities of fluid, e.g., blood, in minutes. In a specific aspect, the micro-fluidic device having a trapezoidal cross section can process 7.5 mL of blood, (e.g., lysed red blood cells) in about 8 minutes, allowing enrichment of viable CTCs, and can process smaller quantities of blood, such as 4 mL in about 5 minutes, and can process larger quantities of blood, such as about 20 mL in about 15 minutes, or 40 mL in about 30 minutes, or 60 mL in about 45 minutes, or 80 mL in about 60 minutes, or larger quantities in more than 1 hour.
In still another aspect, the larger cells can be leukocytes, and the smaller cells can be hematologic cells. In yet another aspect, the mixture can be a bone marrow sample, wherein stem cells can be separated from hematologic cells.
Size based cell separation is a challenging requirement in cell study for the isolation of certain types of cells from cell mixtures. For example, cancer metastasis, mortal consequence of tumorigenesis, accounts for about 90% of all cancer related deaths. During metastasis, viable tumor-derived epithelial cells (circulating tumor cells or CTCs) are shed into peripheral blood of patients with metastatic carcinomas during early stages of tumorigenesis and are probably responsible for extravasation at distant organs to form new metastatic sites. Clinical reports have shown that detection of CTCs can provide valuable insights associated with disease stage and cancer progression. Separation based on size difference between CTCs, which are typically about 20 μm in diameter, and the other blood cells (RBC about 8 μm; leukocytes about 10-15 μm) would be a good way to separate these rare CTCs from hematologic cells.
Another example is neutrophils, which are key effectors of the innate immune response against bacterial infection; over-exuberant response could lead to systemic inflammation and organ dysfunction in sepsis. Therefore, neutrophils themselves have been recognized as a potential target in controlling sepsis. In animal models of sepsis, studies showed that depleting neutrophils or antagonizing their activities helps to maintain organ function. It's tempting to hypothesize that deletion of circulating neutrophils in sepsis patients' blood might help to control inflammation, and a continuous blood separation technique is necessary to validate the hypothesis. Since it's well known that blood cells with various cell types have different cell size, such as polymorphonuclear leukocytes (PNLs) with cell diameter in a range of between about 10 μm and about 15 μm, monocytes and lymphocytes with cell diameter in a range of between about 7 μm and about 8 μm, and erythrocytes with a disk diameter in a range of between about 6 μm and about 8 μm, a size-based separation technique might be helpful in fractionating blood into different blood components.
Mesenchymal stem cells(MSCs) are adult stem cells from bone marrow that can differentiate into multiple non hematopoietic cell lineages. Previous papers have reported that single-cell-derived colonies of marrow stromal cells contained several morphologically distinct cell types. In early colonies, very small round cells rapidly self-renew, as compared with large ones. Samples enriched in the smaller cells had a greater potential for multipotential differentiation than samples enriched in the larger cells. High resolution size based separation is also required for this kind of application.
As a demonstration of MSCs separation, an early passage MSCs cell line was diluted to about 10 k/ml and tested in a 80 μm inner and 130 μm outer height, 600 μm width 8 loops spiral. After experiment, 100 random cells were measured manually from each outlet. The size distribution results are shown in
In the case of a spiral channel having stepped cross-section as shown in FIG. 2-c, the Dean flows near the steps are interrupted by the steps, creating local Dean vortices. Initial results indicate that these vortices have the ability to trap particles within them. A potential application of this type of channel can be as a distributor for high flow rate cell delivery. Cells are trapped at the different positions, which prevent them from being damaged by hitting the channel wall when they are separated to multiple sub-branches.
A spiral microchannel with a sandwiched shallow region between two deeper regions, as shown in
High Resolution Size Based Micro Particle/Cell Separator with Trapezoidal Cross Section Spiral Microchannels
Particle focusing behavior in a spiral microfluidic channel with trapezoidal cross section is described below. By observing the position of a particle stream from both side and top views, combined with numerical simulation of the Dean flow field, the force balance conditions within these channels are studied for better understanding of the particle focusing mechanism in a spiral inertial microfluidic channel. In the spiral inertial microfluidic channel, modifying the channel cross section can lead to a shift in Dean flow field, affecting the particle focusing behavior significantly. Based on this mechanism, particles separation with both high resolution and high throughput is accomplished.Theory
In a rectangular cross-section spiral channel, Dean vortices are symmetrical in the width direction, and particles are mostly focused at the inner side of the curved channel. Particles with diameter/height ratio ≧0.07 normally focus into two streams within the Dean vortex at the top and bottom halves of the channels. With increasing flow rate, the particle focusing position initially moves closer to the inner channel walls due to the increased inertial lift forces, while the centrifugal forces begin to dominate at higher flow rates pushing the particle position away from the inners walls towards the outer wall (
Microfluidic channels were cast from a polymethy methacrylate (PMMA) mold made by a precision milling process (Whits Technologies, Singapore). The design consists of a single inlet, two-outlet spiral channel with multiple loops and curvature radius of about 10 mm. The patterns were cast with Sylgard 184 Silicone Elastomer (PDMS) prepolymer mixed in a 10:1 ratio with the curing agent. After curing, the PDMS mold with patterns was peeled and plasma bonded to another 3 mm thick PDMS layer. Input and output ports were punched prior to bonding. For the observation of particle position from the side, the device was cut along the output section of the channel with about 2 mm distance and then a second cast was made by keeping the device vertical to a flat bottle container. Tubings were connected to the ports before the second cast to prevent PDMS mixer flow into the channel.
During testing, the microfluidic device was placed on an inverted microscope (Olympus X71) and fluorescence images were captured with a Phantom V9.1 camera (Vision Research Inc. USA) near the end of the channel. Input samples were made by diluting 1% solid fluorescent particles (Bangs Laboratories, Inc. USA) of different sizes with DI water and pumped into the channel under different flow rates with a NE-1000 syringe pump (New Era Pump Systems, Inc. USA) to observe the focusing positions. For evaluating the separation quality of the device, higher concentration particles of two different sizes were mixed.Results and Discussion
Previously, particles were assumed to focus at the center of the channel depth in a spiral inertial microfluidic channel, since the Dean drag force (FD∝Uf2, where Uf is the average flow velocity) and the inertial force (FL∝Uf1.63) are dominant at the center area of the channel cross section, while the centrifugal force (FC∝Uf2) is neglected. But according to the experimental result shown in
A trapezoidal cross-section spiral microfluidic channel has been developed for size based particle separation. The experimental results show that the channel is able to achieve high resolution and high throughput cell separation. Particles were successfully separated between 16.68 μm and 26.9 μm particles at 1.33% concentration under a flow rate of 3.4 mL/min with over 96% efficiency, which is the highest throughput and efficiency among microfluidic methods so far. The mechanism of particle focusing was studied by observing the position of force balanced particle streams, along with numerical simulation of Dean flow field. The analysis indicates that particles are focusing at a location where the inertial lift force and the Dean drag force are not dominant, and that centrifugal force should be considered for the explanation of the particle force balance.Example 2
Separation of Leukocytes From Blood Using a Spiral Channel with a Trapezoidal Cross-Section
Inertial microfluidics has recently drawn wide attention as an efficient, high-throughput microfluidic cell separation method. However, the achieved separation resolution and throughput, as well as the issues with cell dispersion due to cell-cell interaction, have appeared to be limiting factors in the application of the technique to real-world samples such as blood and other biological fluids. A novel design of spiral inertial microfluidic (trapezoidal cross section) sorter with enhanced separation resolution is presented herein and its ability is demonstrated in separating/recovering polymorphonuclear leukocytes (PMNs) and mononuclear leukocytes (MNLs) from diluted human blood (1-2% hematocrit) with high efficiency (>80%). PMNs enriched by this method also showed negligible activation as compared to the original input sample, while conventional RBC lysis method clearly induced artificial activation to the sensitive PMNs. Therefore, this technique would be a promising alternative to enrich/separate sensitive blood cells for therapeutic or diagnostic applications.
Red blood cells (RBCs) or erythrocytes are the most abundant cell component in many biological fluids, including blood (where it makes up about 45% of the volume), bone marrow aspirate and peritoneal aspirate. Depletion of contaminating RBCs from those samples is often an indispensable sample preparation step before the application of any scientific, clinical and diagnostic tests due to various reasons. (See Guder, W. G., et al., 1st ed 1996, Darmstadt, Germany: GIT Verlag). For example, inadvertent lysis of RBCs releases hemoglobin, leading to chemical interference and deteriorating the PCR-based test performances. (See Al-Soud, W. A. and P. Rådström, Journal of Clinical Microbiology, 2001. 39(2): p. 485-493). Reports supporting the anti-proliferative and pro-apoptotic role of RBCs in primary cell culture of human cells have also been published. (See Fredriksson, K., et al., Scandinavian Journal of Immunology, 2004. 59(6): p. 559-565. and Atkin, S. L., et al., In Vitro Cell Dev Biol Anim, 1995. 31(9): p. 657-8). While the required degree of RBC removal varies widely depending on the downstream applications, avoiding artificial alteration on the phenotypes of sorted cells is an important criterion for all studies. This is especially important in the case of removing RBCs from human blood to isolate white blood cells (WBCs) or leukocytes, which play a key role in carrying out and mediating the immune response to various pathogens. The information extracted from the isolated leukocytes would be meaningful to facilitate disease prognosis only when the key features of leukocytes' original state are not masked by sample preparation artifacts.
Conventional methodologies for blood cell separation on the macroscale include differential centrifugation and selective RBC lysis. While the performance of differential centrifugation is affected by the blood source, especially for blood from individuals with diseases, such as recurrent infections (See Needham, P. L., Journal of Immunological Methods, 1986. 99: p. 283-284.), the RBC lysis method, which is usually used in combination with the centrifugation to get complete RBC removal, exposes the cells to hypotonic environment, altering cell metabolism in a cell type-specific manner. (See Selzner, N., et al., Cell Death and Differentiation 2004. 11: p. S172-S180). Besides, several cases have been reported stating that those sample preparation procedures could result in altered immuno-phenotype or impaired viability of the isolated WBCs. Moreover, the macroscale sample handling introduces variability to the separation and downstream application results due to imprecise control and non-uniform conditions, making the comparison of analogous results across different laboratories and platforms non trivial. (See Consortium, M.o.t. T. R., Nature Methods, 2005. 2(5): p. 351-356).
Several high-resolution, continuous microfluidic separation techniques (See Hou, H. W., et al., Micromachines, 2011. 2(3): p. 319-343; Toner, M. and D. Irimia, Blood-on-a-chip, in Annual Review of Biomedical Engineering 2005, Annual Reviews: Palo Alto. p. 77-103; Huang, L. R., et al., Science, 2004. 304(5673): p. 987-990; and Yamada, M., M. Nakashima, and M. Seki, Analytical Chemistry, 2004. 76(18): p. 5465-5471) utilizing size-dependent hydrodynamic effects have been reported to achieve the discrimination of few micrometers particle size differences, which is comparable to the intrinsic difference in size observed among blood cells (RBCs: 6˜8 μm discoid; mononuclear leukocytes (MNLs): 7˜10 μm sphere; polymorphonuclear leukocytes (PMNs): 10˜12 μm sphere; WBCs include both MNLs and PMNs). (See Downey, G. P., et al., Journal of Applied Physiology, 1990. 69(5): p. 1767-1778 and Daniels, V. G., P. R. Wheater, and H. G. Burkitt, Functional histology: A text and colour atlas.1979, Edinburgh: Churchill Livingstone.) These approaches are considered to be promising alternatives to bypass the issues associated with macroscale blood cell separation methods mentioned above and are able to process the sample in a label-free and continuous manner. Size-based microfluidic separation techniques do not require the addition of any lytic agent or prior cell labeling treatment and allow better control of the microenvironment during the blood sample handling. The cell separation is achieved by driving individual cells uniformly through a microchannel with well-designed geometry, which leads to the alignment of cells in different positions across the channel width in a cell-size-dependent manner, followed by continuous sample collection at different outlets. The channel design is extremely critical for both the separation resolution and throughput, and differs as the working principle of the exact size-based hydrodynamic effects varies. In one example, a “deterministic lateral displacement (DLD)” microchannel containing an array of microposts leads to differential lateral displacement for particles above or below the critical hydrodynamic diameter as a result of the asymmetric bifurcation of laminar flow around the microposts. (See Huang, L. R., et al., Science, 2004. 304(5673): p. 987-990). In another type of microfluidic device, “pinched-flow fractionation (PFF)” patterned with a contraction-expansion segment (See Yamada, M., M. Nakashima, and M. Seki, Analytical Chemistry, 2004. 76(18): p. 5465-5471), the parabolic velocity profile of laminar flow within the contraction region leads to the alignment of particles near the channel sidewall in a size-based manner, so that large particles with comparable diameter to the channel width of the contraction region stay closer to the middle streamlines, but smaller particles have their center closer to the channel sidewall. This difference in lateral positions of particles with varying size is further amplified upon entering the expansion region, resulting in efficient separation. Both techniques have the high resolution required for separating RBCs from other cell types but are severely limited in their practical application on clinical samples by the low processing throughput. On the other hand, inertial microfluidics-based techniques using Dean flows in curvilinear microchannels with rectangular cross-section has been reported to achieve high throughput size-based particle separation (See Di Carlo, D., et al., Proceedings of the National Academy of Sciences, 2007. 104(48): p. 18892-18897 (hereinafter “Di Carlo et al., 2007”); Bhagat, A. A. S., S. S. Kuntaegowdanahalli, and I. Papautsky, Lab on a Chip, 2008. 8(11): p. 1906-1914; Di Carlo, D., et al., Analytical Chemistry, 2008. 80(6): p. 2204-2211; Kuntaegowdanahalli, S. S., et al., Lab on a Chip, 2009. 9(20): p. 2973-2980 and Seo, J., M. H. Lean, and A. Kole, Applied Physics Letters, 2007. 91(3): p. 033901-3).
As described below, the separation resolution of curvilinear microchannels has been improved, while maintaining the high-throughput feature, by modifying the channel cross-section to be trapezoidal rather than rectangular, and its ability is demonstrated below for efficient RBC depletion from a human blood sample with negligible effects on PMN immuno-phenotype. Moreover, to fit the needs of processing samples with volume ranging from microliter to milliliter scale, the current design can directly process the diluted whole blood sample when the blood sample volume is on the order of a microliter, (e.g. fingerprick), and as a replacement for the RBC lysis method, it can also be used in combination with differential centrifugation to get pure WBCs with no sign of alteration in activation status of the sorted cells for a larger sample volume (e.g., about 1 mL). The trapezoidal cross-sectional spiral microchannel described herein can be used as a generic, highthroughput method for removing RBCs and enriching target cells from other biological fluids, such as harvesting mesenchymal stem cells (MSCs) from bone marrow aspirates.Materials and Methods Microchannel Fabrication
The trapezoid cross-sectional spiral channels were made of polydimethylsiloxane polymer (PDMS, Sylard 184 Silicone Elastomer Kit, Dow Corning, USA) using standard soft lithography techniques from a poly(methyl methacrylate) (PMMA) master template. The PMMA template master was fabricated by a milling process (Whits Technologies, Singapore) to meet the special requirements in cross-sectional geometry. Given the available milling machine capability, the actual pattern of the template mold had a tolerance of ±10 μm compared to the virtual design, and a surface roughness of Ra=0.8 μm. Subsequently, PDMS prepolymer mixed with curing agent in a 10:1 (w/w) ratio was then cast on the PMMA template master and cured under 80° C. for 2 hours to replicate the microchannel features. The cured PDMS molds were peeled off from the PMMA master and punched for the inlet and outlet reservoirs using a 1.5 mm-diameter biopsy punch. Finally, the PDMS molds were irreversibly bonded to another flat 0.5 cm-thick PDMS sheet following oxygen plasma treatment (Harrick Plasma Cleaner/Sterilizer, Harrick Plasma, Inc., USA), The resulting PDMS devices were cut at four different locations and the cross-sections were measured under microscope to determine the exact dimensions of the devices. The rectangular cross-sectional spiral channels were also fabricated in PDMS polymer, but by using a double molding process from an etched silicon wafer master (See Bhagat, A. A. S., et al., Lab on a Chip, 2011. 11(11): p. 1870-1878). Briefly, positive AZ4620 photoresist was first patterned on a 6-inch silicon wafer to define the microchannel features. Then, the patterned wafer was etched to the desired depth using deep reactive ion etching (DRIE), followed by residual photoresist removal using oxygen plasma treatment. Next, trichloro(1H,1H,2H,2H-perfluorooctyl)silane (Sigma-Aldrich, USA) was coated on the etched wafer for 1.5 hours (h) to assist PDMS mold release. PDMS liquid mixture with 5 parts of prepolymer and 1 part of curing agent was then poured onto the silicon wafer and cured under 80° C. for 2 hours. The resulting PDMS mold had channel features protruding from the surface and served as a master for subsequent PDMS molding. The silane treatment and PDMS curing was repeated with this PDMS master to get a negative replica. As a last step, the negative replica, with inlet and outlet reservoirs punched, was bonded to another PDMS substrate by standard plasma-assisted bonding.Sample Preparation
For bead experiments, fluorescent polystyrene particles (1 wt. % solid content) with a diameter of 6 μm (5.518 μm±0.122 μm), 10 μm (10.3 μm±0.4 μm) (Polysciences, Inc., USA), or 15.5 μm (15.5 μm±1.52 μm, Bangs Laboratories, Inc.) were diluted in deionized water (0.1% volume fraction) containing 0.025 mg/mL PEG-PPG-PEG Pluronic® F-108 (Sigma-Aldrich, USA), respectively, serving as the input sample. The small amount of PEG-PEG-PEG Pluronic® F-108 added was not enough to change the viscosity and density of the fluid but minimized the non-specific adherence of the particles to the channel walls. (See Inglis, D. W., et al., Applied Physics Letters, 2004. 85(21): p. 5093-5095).
For experiments with blood samples, fresh human whole blood from healthy donors with sodium heparin as anti-coagulant was purchased from Research Blood Component, LLC (Boston, Mass., USA) and processed within 6 hours after collection to ensure viability of PMNs. The PMNs and MNLs were isolated using Mono-Poly Resolving Media (MP-RM; MP Biomedicals, LLC, USA). Briefly, a 15 mL centrifuge tube containing 3.5 mL of whole blood layer atop a 3 mL MP-RM layer was centrifuged under 300 g for 30 min with brakes off. The bands of cells containing MNLs and PMNs were collected in separate tubes, washed and resuspended in sample buffer (1× PBS with 0.5% BSA), respectively. The isolated MNLs and PMNs could also be mixed together, serving as the representative WBC sample isolated via differential centrifugation. WBCs isolated using selective RBC lysis method were obtained by treating whole blood with RBC lysis buffer (eBioscience Inc., USA) (1:10) for 10 minutes, followed by washing and resuspension in sample buffer. Finally, for blood samples, whole blood was spun down at 400 g for 10 minutes with brake off to obtain the cell and plasma fractions. The cell fraction was then resuspended in sample buffer and adjusted to varying hematocrits (0.5-2% hematocrit) to constitute the various samples.Device Characterization
The device was mounted on an inverted phase contrast/epifluorescence microscope (Olympus IX71, Olympus Inc., USA) equipped with a 12-bit CCD camera (C4742-80-12AG, Hamamatsu Photonics K.K., Japan). Samples were loaded within a syringe and pumped through the microchannel at varying flow rates using a syringe pump (Harvard Apparatus PHD 2000, Harvard Apparatus Inc., USA). To prevent the particle/cell sedimentation, a small magnetic stir bar placed inside the syringe was agitated during sample processing. Using ImageJ ® software, the positions of fluorescent particles within the channel cross-section were determined by taking the average fluorescence intensity of the image series. For cells, high speed videos captured using a high-speed camera, Phantom v9.1 (Vision Research Inc., USA) under phase contrast were analyzed to determine the cell positions. The standard deviation of light intensity of the high speed video was calculated to visualize the positions of fast moving cells.FACS Analysis
All antibodies were purchased from BD Pharmingen™ (BD Biosciences, USA). To determine the separation efficiency, whole blood was stained with 0.1 mg/ml Hoechst 33342 (Invitrogen, USA) and FITC-conjugated mouse anti-human CD66b monoclonal antibody (1:25 v/v) for 30 minutes at 4° C. in the dark. The stained blood cell fraction was then collected by centrifugation and resuspended in sample buffer to the desired hematocrit as the input sample. Both the input sample and the output samples from two outlets were collected and analyzed on BD™ LSR II flow cytometer (BD Biosciences, USA) to determine the WBCs (Hoechst-positive cells) and PMNs (CD66b-positive cells) in each sample. Given the fact that MNLs comprise various cell types and there are no convenient surface markers available to determine the total amount of MNLs, the MNL count was based on the number of Hoechst-positive but CD66b-negative cells. Additionally, the RBC concentration was further measured by Z2 Coulter counter (Beckman Coulter Inc, USA). Similarly, to evaluate the device performance on buffy coat sample, WBCs isolated by centrifugation with MP-RM were stained for surface marker, CD66b, and nucleus. The stained WBCs were then resuspended in sample buffer with the same volume of the initial whole blood volume and processed by the device. Next, the size distribution of cells in the sample was measured by Z2 Coulter counter and a flow cytometer was used to analyze the sample composition.
For comparison between different RBC removal techniques, whole blood (without staining) was diluted to 1% hematocrit in sample buffer and then processed by the microchannel device. Subsequently, input and output samples of the device, as well as the WBCs isolated by differential centrifugation with MP-RM or by 10 minutes of hypotonic RBC lysis (methods described in the sample preparation section above), were stained with FITC-conjugated mouse anti-human CD66b monoclonal antibody (1:25 v/v) and APC-conjugated mouse anti-human CD18 monoclonal antibody (1:25 v/v) for 30 minutes at 4° C. in the dark. After staining, the samples were washed with sample buffer and analyzed on a flow cytometer. The gates for activated PMNs (i.e., CD18-positive PMNs), were drawn based on PMNs treated with 30 minutes of 1 μM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, USA) under 37° C. (complete activation achieved), followed with immunofluorescence staining and FACS analysis.Nitro Blue Tetrazolium (NBT) Test
The WBCs isolated by differential centrifugation with MP-RM and the WBCs isolated by the spiral process with 1% hematocrit input sample were resuspended in sample buffer to a final concentration of about 1 million cells/mL. 40 μL of each cell sample was deposited onto Poly-L-lysine coated glass slide (Sigma-Aldrich, USA), respectively, where the sample region had been circled using Hydrophobic Barrier Pen (ImmEdge™ Pen, Vector Laboratories, Inc., USA). Samples on the slide were then incubated at 37° C. for 10 minutes to allow the cell attachment. The assay buffer for NBT test was freshly prepared and consisted of 1× Ca2+/Mg2+-containing DPBS buffer (Dulbecco's Phosphatase Buffered Saline; Invitrogen, USA) and 0.25% (w/w) NBT (Sigma-Aldrich, USA). For the conditions with PMA stimulation, the assay buffer also contained 1 μM PMA. After incubation, 40 μL of assay buffer was added onto the slide for 20 minutes of incubation at 37° C. Lastly, the cell sample was observed under phase contrast microscope (Olympus C10 (41, Olympus Inc., USA) and color images were taken by a DSLR camera (Canon EOS 500D, Canon, USA) with a 60× objective under microscope using a NDPL-1 (2×) connecting lens (Vivitar® Sakar International, Inc., USA).Results and Discussion Design Principle
When flowing through a microchannel, particles suspended in a fluid experienced inertial lift forces and viscous drag. Inertial lift forces include the shear-induced lift force resulting from the parabolic velocity profile of flows in a confined channel (See Di Carlo et al., 2007) and the wall-induced lift force arising from the disturbed rotational wake around the particles when close to the wall (See Zeng, L., S. Balachandar, and P. Fischer, Journal of Fluid Mechanics, 2005. 536: p. 1-25). For particles satisfying ap/Dh≧0.07 (where ap represents particle diameter, and Dh=4A/P is the microchannel hydraulic diameter, A and P are the area and perimeter of channel cross-section, respectively), the interplay between shear-induced and wall-induced lift forces leads to lateral migration of the initial randomly distributed particles to stable equilibrium positions around the microchannel periphery. (See Di Carlo, D., et al., 2007; Bhagat, A. A. S., S. S. Kuntaegowdanahalli, and I. Papautsky, Lab on a Chip, 2008. 8(11): p. 1906-1914 and Di Carlo, D., et al., Analytical Chemistry, 2008. 80(6): p. 2204-2211). Many studies revealed that the net inertial lift force (FL) acting on the particles is highly dependent on particle size (FL ∝ ap4) and fluid shear rate (FL ∝ G2). Apart from these, the resulting equilibrium positions are also affected by the geometry of the channel cross-section. Within a square cross-sectional straight microchannel, particles focus at 8 equilibrium positions in low Reynolds number flows (Rec<100, where
and ρ, Uf, μ represent the density, velocity and viscosity of the fluid medium separately) but 4 equilibrium positions near channel corners when the Reynolds number is high (Rec≧500). (See Chun, B. and A. J. C. Ladd, Physics of Fluids, 2006. 18(3): p. 031704). The asymmetric nature of the shear rate in a rectangular cross-sectional microchannel with high aspect ratio results in preferential focusing of particles along the longer channel dimension. (See Bhagat, A. A. S., S. S. Kuntaegowdanahalli, and I. Papautsky, Microfluidics and Nanofluidics, 2009. 7(2): p. 217-225). Incorporation of channel curvature could further modify the equilibrium positions by exerting viscous drag of secondary flow on particles. Fluid passing through a curved microchannel, such as a spiral channel, is subjected to centrifugal acceleration generating a secondary flow composed of two counter-rotating vortices (Dean vortices) across the channel cross-section. (See Dean, W. R., Philosophical Magazine Series 7, 1927. 4(20): p. 208-223 and 29. Dean, W. R., Philosophical Magazine Series 7, 1928. 5(30): p. 673-695). The magnitude of the vortex flow can be expressed using the non-dimensional Dean number (De) and the viscous force, known as Dean drag force (FD), experienced by the particles can be quantified by assuming Stokes drag.
where UD represents the average velocity of Dean flow given by UD=1.8×10−4 De1.63. Notably, although it is not clearly indicated in the expression of Dean drag force, both its magnitude and direction varies within the channel cross-section since the secondary flow velocity differs at different locations of Dean vortices and is almost zero at the vortex core. (See Ookawara, S., et al., Chemical Engineering Science, 2007. 62(9): p. 2454-2465). While the inertial lift force primarily dictates the particle focusing, the combinatory effect of Dean drag force and inertial lift force within the spiral channel reduces the multiple equilibrium positions of particles into two vertically overlapping positions with the same lateral distance to the inner channel wall. (See Russom, A., et al., New Journal of Physics, 2009. 11: p. 075025). Furthermore, as a result of the size-dependence of both forces (FL∝ap4, FD∝ap), particles with varying diameters occupy distinct lateral positions near the inner channel wall and demonstrate different degrees of focusing when flowing through the same spiral channel under a given flow rate. Thus the spiral microchannel can be applied as a possible size-based particle/cell separation device.
One major challenge of utilizing spiral microchannels in blood cell separation lies in the limited separation resolution and capacity of holding vast number of RBCs without affecting the separation efficiency. One recent work showed that polystyrene particles with a diameter of 7.32 9.92 μm, 15.02 μm and 20.66 μm, respectively, could focus into four distinct bands in a spiral microchannel with 500 μm×100 μm (W×H) rectangular cross-section at De=16.3, at a very low concentration (0.005% volume fraction particle solution). (See Chatterjee, A., S. S. Kuntaegowdanahalli, and I. Papautsky, Proceedings of the SPIE, 2011. 7929: p. 792907). However, this design cannot be directly applied to blood samples where the vast number of RBCs significantly broaden the stream width of RBCs due to cell-cell interactions and affect the focusing of other cells. To accommodate the samples with higher hematocrit, the spacing between equilibrium positions needs to be increased. The approach presented herein is to modify the spiral microchannel cross-section into a trapezoid with higher channel depth on the outer channel wall, as shown in
The trapezoidal cross-section also has an impact on the size- and flow-rate-dependence of particle focusing. In a rectangular cross-sectional spiral, particles with ap/Dh≧0.07 initially focus near the inner channel wall at low Rec, and then move towards the outer wall as Rec increases. When Rec is sufficiently high, Dean drag force dominates the particle behavior leading to defocusing of particles. On the contrary, the results presented herein indicate that instead of Dh, the channel depth at the inner wall (Dinner) serves as a better critical channel dimension to determine whether particles of a certain diameter can form a focused stream near the inner wall. This was confirmed by using trapezoid channels satisfying a Douter/Dinner≦1.5 criterion as shown in
The optimized PDMS device for RBC removal developed herein consists of a 1-inlet, 2-outlet spiral microchannel with a trapezoidal cross-section of 500 μm width (485.00 μm±2.31 μm), 70 μm (inner wall, 72.84 μm±1.16 μm) and 100 μm (outer wall, 102.65 μm±3.55 μm) depth. Near the outlet region, the 485 μm wide channel was split into two outlet channels with a channel width ratio of 3:7 (inner:outer), while their channel lengths were adjusted to be equal with each other. The inner outlet was defined to be the WBC outlet with RBC-depleted sample (i.e., PMNs/MNLs) and the outer outlet to be the RBC waste outlet The optimal flow rate was experimentally determined to be 0.8 mL/min (Rec=46.52; De=4.22). PMNs and MNLs isolated via centrifugation using MP-RM were injected through the device separately to determine their equilibrium positions inside the channel, shown in
The device can also be used as a secondary step of differential centrifugation, whose performance was subjected to variance of blood source and manual transfer of different cell layers to different tubes. It is often the case that some RBC residuals stay with the isolated WBCs after the first 30-min centrifugation and additional slow centrifugation washing steps or RBC lysis step are required for further RBC removal. Here, the RBC removing ability of this device was demonstrated in processing buffy coat in a case where notable amounts of RBCs were isolated along with WBCs by centrifugation (
Gentle depletion of RBCs from a sample is crucial for the downstream analysis of remaining cells. In a recent study, the overall gene expression profile and cell viability was measured for cancer cells, MCF7, after inertial separation under Rec=21 and no significant effects caused by the separation process were observed compared to the unsorted control sample (See Hur, S. C., et al., Lab on a Chip, 2011. 11(5): p. 912-920), indicating that transient exposure of cells to a shear condition in a short time scale might not be enough to change the cell function. For the spiral device described here, the viability of isolated WBCs was found to be 98.22%±0.83% (trypan blue staining; input: 98.05%±1.08%) and their ability of producing reactive oxygen species in response to in vitro stimuli (PMA) has been measured by the NBT test. As shown in
A novel, high-throughput RBC removal technique has been developed using a trapezoidal cross-sectional spiral, which provides higher resolution separation as compared to a rectangular cross-section with similar dimensions, as shown by an experimental demonstration where the asymmetry velocity field within a trapezoidal spiral channel affects the inertial focusing phenomenon, indicating the feasibility of using channel cross-sectional geometry (other than width and depth) as a parameter for optimization of a curvilinear inertial microfluidic sorter. This size-based separation technique eliminates the need for long-term exposure of blood cells to nonphysiological conditions and thus minimizes artificial alterations on cellular phenotypes during separation. While clogging and low throughput are major drawbacks for most microfluidic size-based separation methods which utilize membranes (See Bruil, A., et al., Journal of Biomedical Materials Research, 1991. 25(12): p. 1459-1480) or micron-sized pillars (See Panaro, N. J., et al., Biomolecular Engineering, 2005. 21(6): p. 157-162), the relatively large dimensions of the device described above enable large volume sample processing with no clogging issues. As compared to other types of continuous cell separation methods, such as DLD and PFF techniques, the spiral microchannel described above functions at a high operational flow rate (in the mL/min range) with large channel dimensions accommodating the abundant RBCs (up to about 2% HCT), and thus possesses high throughput and is amenable to process blood samples. The highly repeatable performance and ability in enriching WBCs to >90% of total cell population also makes it a good choice to completely deplete RBCs from various biological fluids when used alone or in combination with differential centrifugation. Further optimization of channel cross-section and other structural features is possible to apply this technique to many other primary cell separation problems.Example 3 Spiral Microchannel With Rectangular and Trapezoidal Cross-Sections for Size Based Particle Separation
A method for three-dimensional observation of the location of focused particle streams along both the depth and width of the channel cross-section in spiral inertial microfluidic systems is described below. The results confirm that particles are focused near the top and bottom walls of the microchannel cross-section, revealing clear insights on the focusing and separation mechanism. Based on this detailed understanding of the force balance, a novel spiral microchannel with a trapezoidal cross-section is introduced that generates stronger Dean vortices at the outer half of the channel. Experiments show that particles focusing in such device are sensitive to particle size and flow rate, and exhibit a sharp transition from the inner half to the outer half equilibrium positions at a size-dependent critical flow rate. As particle equilibration positions are well segregated based on different focusing mechanisms, a higher separation resolution is achieved over spiral microchannels with rectangular cross-section.
Particle focusing positions in rectangular and trapezoidal cross-section spiral channels
In a spiral channel with trapezoidal cross-section, the particle focusing behavior is different from that in a rectangular channel. In a trapezoidal channel, as shown in
Measurements of the focusing position of particles with different sizes in trapezoidal channel demonstrate clearly distinct characteristics. As shown in
For the separation of particles of two different sizes, the ideal scenario is for particles of different sizes to focus at positions as far as possible from each other. This will not only increase the separation resolution, but also allows one to process samples with higher particle concentrations by minimizing the interaction between particles of different sizes (e.g., high hematocrit cell solutions in the case of blood separation). The results in
The high throughput separation capability of trapezoidal channels is presented in
Cells are different from rigid particles in terms of the deformability and shape. Hur et al. have reported that the shape of particles does not have an obvious influence on the focusing position in inertial microfluidics, but the hydraulic diameter of particles is the key factor, while the deformability has an evident effect on the focusing position of particles/cells, which makes the focused band of particles/cells slightly shift away from the channel wall as compared to that of rigid beads of the same size. If the device is employed in cell separation, the variation of cell deformability may affect the separation efficiency. But as shown in Example 2 above, the trapezoidal spiral is capable of producing comparable separation between deformable leukocytes and red blood cells, perhaps aided by the large distance between the inner focusing and outer trapping positions.Force Balance Analysis and Focusing Mechanism in Rectangular Cross-Section Channel
For the analysis of the forces exerted on a particle in curved microchannel, a coordinate system (x, y, z) is defined as shown in
Along the cross-section, the Dean induced drag force FDD and the inertial lift force FL are dominant among all of the forces exerted on the particles suspended in a spiral channel (details of force analysis can be found below). The equilibrium position of particles is thus dependent on the balance between these two forces.
For a particle balanced at a certain position of the channel cross-section, the difference in particle velocity along the y-z plane and the Dean flow velocity in its proximity could generate a drag force on the particle that follows Stokes' law (i.e., drag force being proportional to Dean velocity) as illustrated in
Small particles in a shear field experience a lift force FL that is perpendicular to the direction of the flow as a result of the inertial effects in the viscous flow around the particles. For the above designs of microfluidic channel, FL is dominant in most locations compared to FDD, except near the ‘minimal lift force’ regions. Although so far there has been no simulation result for the distribution of FL in low aspect ratio rectangular channel, at the center region of the channel cross-section, FL always points toward the channel top or bottom wall.
Near the channel wall, the lift force balance in a straight channel has been numerically simulated and experimentally observed in previous studies. The direct observation of focusing position in the cross-section of square channel by Choi indicated that particles will balance close to the four channel walls, which are named the “minimum lift force planes”. Bhagat et al., observed the distribution of fluorescent particles from both top and side views and showed that for a rectangular straight channel, the four minimum lift force planes reduce into two minimum lift force planes along the longer side walls. Other results agree with their observation in the curved channel, in the sense that particles focused at the 22% and 78% of the channel depth along the top and bottom channel walls in the rectangular cross-section curved channel. Furthermore, according to their experimental data, particles remain dispersed along the minimum lift force planes at low flow rates, and will focus to the centers of the minimum lift force planes as the flow rate increases. This experimental behavior in a straight rectangular channel, coupled with numerical calculation, reveals that FL within the minimum lift force plane is still pushing particles toward the true equilibrium (center of the planes). While this force is weak at low flow rates, it leads to particles being dispersed along the planes. With higher flow rates, FL increases more rapidly (FL˜Um2, where Um is the mean velocity of main flow) and becomes significant, leading to particles being focused at the center of the minimum lift force planes.
The behavior of particle in a curved rectangular channel can similarly be explained. Because there is no FDD in the y direction except near the side wall regions, the focusing position of all the particles along the y axis is determined by FL, which focuses particles at 22% and 78% of the channel depth as in the straight rectangular channel. At these minimum lift force planes (22% and 78%), the Dean flow pushes the particles toward the inner wall until the particles start to experience a weaker FDD (due to edge effect, around 10% of the width from the inner wall) and are balanced by weak FL within the minimum lift force planes. This (position a in
When the flow rate increases (above about 3 mL/min in
On the other hand, particles at the center line (particle d in
Notably, the above analysis does not consider the interaction between the particles and the flow field. In fact, it has been proposed that the presence of the particles could change the distribution of main flow dramatically, and even induce lateral flow. The change of the main flow can directly affect FL and FDD. Since the Dean flow is caused by the heterogeneity of the main flow, the distribution of Dean flow will also be modified by both the change of the main flow and the particle induced lateral flow, changing the magnitude of FDD in turn. Therefore, it would be difficult to give a quantitative analysis of these forces even when the simulation data of FL in a straight channel is available. However, based on this simplified force analysis, one can still get a qualitative understanding of the force balancing within spiral inertial microfluidic channels, where the lift force is primarily balanced by the drag force.Focusing Mechanism in a Trapezoidal Channel
In rectangular cross-section channels, particles focus at certain positions (typically at the inner side of the curved channel) as a result of the balance between FDD and FL. If any force is changed, the balance is broken and the particles will shift to a new focusing position in the cross-section. The modification of the focusing position can be easily achieved by altering the geometry of the channel's cross-section. A trapezoidal channel with shallow inner and deep outer cross-section, for example, causes the main flow to shift towards the outer side of the channel cross-section. This generates a stronger Dean flow at the outer side and a weaker Dean flow at the inner side (
Within the inner half of trapezoidal cross-section, the distribution of the Dean flow is similar to that in a rectangular cross-sectional channel, despite the lower magnitude, since the center of the Dean vortices are far away from the inner wall. At low flow rates, where the lift force is not high enough to push particles away from the inner side, the large particles will remain focused near the inner channel wall, as in the case of rectangular channels. With increasing flow rates, particles begin to move towards the outer wall due to the increase in FL along z-axis. FDD has two components here, a component along y-axis pointing toward the center of channel cross-section near “zero Dean flow plane”, termed as FDy and the corresponding component along z-axis, termed as FDz. From
Once the particle moves to the outer half of the channel near one of the vortex centers, the resultant force of FDD and FL will push the particle to an equilibrium position close to the center of the vortices. The forces acting on the particle near vortex center are illustrated in
A trapezoidal cross-section with a deeper inner wall compared to the outer wall will have strong vortices formed at the inner side, resulting in all the particles being trapped despite varying particle size and flow rate. Such geometry is not applicable for size based separation. Microchannels were also fabricated with the top wall having a concave, convex or just a regular slanted top wall and their effect on particle focusing and trapping was studied. The experimental comparison of these three patterns is discussed below.
For a trapezoidal cross-section spiral microchannel, there are several factors that affect the focusing position and separation efficiency, such as the width, inner and outer depth of channel cross-section, the radius of the spiral curvature, and the slant angle. As analyzed above, the slant of the channel affects the focusing.behavior in two ways: (i) the threshold flow rate required to trap particles in the Dean vortex as a function of particle size and (ii) the location of the Dean vortex core. A large slant angle will lead to strong Dean at the outer side and increase trapping capability of particle. Large slant angle can also decrease the threshold flow rate required to trap the particles of a certain size within the Dean vortex. This understanding was further validated by the observation of particle bands in channels with different slant angles and three different channel cross-section geometries (data and discussion included below).
Experimental results confirming the three dimensional particle focusing in spiral microchannels are presented herein. The results indicate that particles form two bands along the depth symmetrically between the zero-lift force plane and the centers of the Dean vortex in spiral channels. Based on the experimental evidence and the numerical simulation of the Dean flow profile, a detailed explanation of the focusing mechanism is presented, taking into account of various forces acting on the particle. With this understanding of the particle focusing mechanism, a trapezoidal cross-section spiral microchannel for particle separation was developed and analyzed. A multi-loop microchannel was employed to calibrate the focusing of different size standard micro particles of 5.78 μm, 9.77 μm, 15.5 μm, and 26.25 μm diameter for flow rates ranging from 0.5-7.5 mL/min. The experimental results indicate that particles occupy an equilibrium position near the inner microchannel wall when particles are introduced under a lower flow rate. However, beyond a threshold flow rate (which is size-dependent) the equilibrium position is moved to the outer microchannel wall, suggested to be a Dean vortex trap. Taking advantage of this sudden transition, the trapezoidal cross-section spiral microchannel is capable of producing higher resolution separation of particles than conventional rectangular cross-section spiral. Separation of 15.5 μm and 18.68 μm beads at an ultra-high throughput of about 1.61×107/min with over 92% efficiency was achieved with this device.Methods Device Design and Fabrication
Pressure-driven flows through a rectangular channel have a hyperbolic profile with the maximum velocity at the centroid of the cross section of the channel and zero velocity at wall surfaces. Particles suspended in such non-uniform flow fields experience appreciable inertial lift force resulting in their focusing at specific positions within the microchannel cross section. In a curved channel, the fluid experiences centrifugal acceleration directed radially outward giving rise to transverse flows characterized by two counter-rotating vortices, known as Dean vortices, at the top and bottom halves of the channel (see
Although inertial focusing within straight channels has been reported to require only 4 cm, the Dean vortices generated in curvilinear microchannel apply additional force on the particles, requiring longer channel length for the suspended particles to migrate to their balancing position. Considering this, all the microfluidic channels used in these experiments were designed to be 8-loops single-inlet two-outlet spiral with radius increasing from 8 mm 24 mm to provide sufficient length for the particle migration. Since the dimensions of the channel are in sub-millimeter range, the master mold with the specific channel cross-sections for subsequent polydimethylsiloxane (PDMS) casting was milled in polymethyl methacrylate (PMMA). Due to the limitation of the milling tool, the tolerance of the pattern is controlled to within 10 μm in the x-y direction and 2 μm in the z-direction with a surface roughness of Ra of about 0.8 μm. The mold was carefully inspected and its dimensions were measured accurately before use. The microchannels were then made by casting Sylgard 184 silicone elastomer (PDMS) prepolymer mixed in a 10:1 ratio with the curing agent. After curing, the PDMS was peeled from the mold and plasma bonded to another 3 mm thick flat PDMS layer. Input and output ports were punched prior to bonding.
For the measurement of the vertical focusing positions, the device was cut along the periphery of the spiral channel with about a 2 mm gap between the channel and the edge of the PDMS part. The PDMS mold with the microchannel pattern was then placed vertically in a flat-bottomed petri-dish and a second cast of PDMS was poured to hold the chip vertically (
For the observation of particle focusing from the side view, a spiral channel with a low aspect ratio rectangular cross-section was fabricated. The microchannel was 600 μm wide and 80 μm deep, with the aspect ratio of 7.5 (width/depth). If the refractive index difference between the fluid and PDMS channel is large, the imaging of fluorescent particles within the channel through a thick piece of PDMS is challenging due to significant refraction at the interface. To overcome this, dimethyl sulfoxide (DMSO) was mixed with ethanol in a 1:1 volume ratio, which produces a mixture with refractive index of 1.42, density of 0.9805 g/ml and viscosity of 0.978 mPa·s at 298.15K. The refractive index of the mixture is similar to that of PDMS (1.43) and enhances imaging by elimination of refraction based dispersion. The solution was shown to dissolve the polystyrene (PS) particles (Bangs Laboratories, Inc. USA) and Tygon tubing after prolonged immersion of 1 week. However, for the short duration of the experiments, the fluid mixture had no effect on both the particles and the tubings, making it an ideal replacement to water for the experiments.Numerical Simulation
The Dean flow field of the fluid in curved channel was simulated using commercial computational fluid dynamics (CFD) software COMSOL 4.2a (Burlington, Mass.). Curved micro-channel sections with different cross sectional geometries were modeled as a 120° arc with a radius of 7.5 mm. The parameters of the density and the dynamic viscosity of the fluid in the channel section were set to that of water. The equations of laminar flow used in this simulation are given by ρ(u·∇)u=∇·[−pI+μ(∇u+(∇u)T)]+F and ρ∇·u=0, where the symbols follow the default definition in COMSOL. The physical model was set to be incompressible and non-turbulent. The inlet boundary condition was set with the specified flow rate while the outlet was set to zero pressure with no viscous stress condition. At the channel walls, no slip boundary condition was applied. Typical flow rates from 1.0 mL/min to 8.0 mL/min were simulated to get the full solution for fluid flow at the steady state. Components of the flow velocity within the cross-section, i.e., the secondary Dean flows, were extracted at the center of the arc.Discussion Force Balance Analysis of Particle in Curved Channel
A particle flowing with surrounding fluid is subject to the following known forces: the drag force FD, the centrifugal force FC, the buoyancy force, i.e., the pressure gradient force FB, two unsteady forces due to a change of the relative velocity, the added mass force or virtual mass force FA, and the Basset History force FH, the gravitational force FG, and the inertial lift force FL. Each of these forces will be discussed as applied on the suspended particles in the inertial flow regime.
- (i) Drag force FD—The drag force on the particle is in the direction of relative flow velocity Ur with respect to the particle. The magnitude of FD can be given as
where CD is the drag coefficient, ρf is the density of fluid, and r is the radius of particle. In a curved channel with secondary flow, Ur is a combination of two perpendicular relative flow velocities: the slip velocity Us along the main flow, which is refer to the velocity difference between particle and fluid along x direction, and the Dean velocity UD for a particle focused at a balanced point in the channel's cross-section. Thus we have Ur=Us+UD as shown in
According to Yang's simulation, in a tube Poiseuille flow with a freely rotating particle of a radius r=0.075 D at equilibrium position under moderate Reynolds number
where Um is the mean velocity of the main flow in the channel, D is the hydraulic diameter of the tube (equivalent to the depth of the channel here), and μ is the dynamic viscosity of the fluid, the flow velocity of particle Up is smaller than that of the surrounding fluid Uf. The slip velocity is given by
For a given point, UD, according to the simulation result for an 80 μm deep 600 μm wide rectangular cross-section channel, is generally proportional to Re2, i.e. the magnitude of Um2, which is different from Ookawara's result of UD˜Um1.63. The disagreement might be due to the difference of structural parameters between the two models. From
- In this system, for flow rates from 1.0 to 8.0 mL/min, one has the Reynolds number of the particle
calculated based on the above analysis of Ur. Based on Morsi's analysis/model, the CD for 0.1<Rep<1.0 and 1.0<Rep<10.0, could be estimated by equation
respectively. Here, to simplify the analysis, the first-order approximation is taken,
which will make the calculated FD slightly smaller than the actual value. The drag force then follows Stokes Law as
The component of FD induced by the Dean flow in the channel's cross-section is thus given by
- Although there is shear in the Dean flow and the particle will rotate according to both the shear of the main flow and the Dean flow in the channel, Kurose demonstrated that the shear rate and rotation velocity caused by the Dean flow do not have significant effect on the direction and magnitude of the drag force at Rep in above range. The Dean induced drag FDD is thus always along the Dean direction and is proportional to the local Dean velocity UD.
- (ii) Lift force FL—Since UD is two orders of magnitude smaller than Um in the curved channel, here one only considers the lift force induced by the main flow. The lift force comes from two separate effects: the slip-shear of the fluid surrounding the particle, which is first identified by Saffman, and the slip rotation of the particle in fluid, known as the Magnus effect. The distribution of FL in a square cross-section straight channel was studied by others, however no mathematical calculations were given. Here, to show the relationship between FL and the flow velocity as well as the particle diameter, the lift force equation of a freely rotating particle in steady flow within a cylindrical tube by Yang is used. In a tube Poiseuille flow with a freely rotating particle of radius r=0.075 D near the equilibrium position,
where D is the (hydraulic) diameter of tube, ωd and ωe are the slip angular velocities of the particle at a position with relative distance d from the center of the tube's cross-section and equilibrium position respectively. The term ωd/ωe is a function of particle position d and Reynolds number Re
FL is zero at the equilibrium position, which is around 20% of D from the wall, and changes its direction when the particle moves across the equilibrium position. The magnitude of FL near the equilibrium position, according to above equations, is approximately proportional to UmUs˜0.05 Um2.
- (iii) Centrifugal force FC—For a particle flowing in a curved channel with the radius of curvature R, the centrifugal force subjected to the particle is pointing towards the outer side of the channel along the z direction and is proportional to Up2):
is the mass of the particle. ρp and Vp represent the density and volume of the particle, respectively.
- (iv) Buoyancy force FB—In a fluid with constant pressure gradient, particles are subjected to a buoyancy force pointing to the center of the channel curvature, i.e., along the z-axis direction,
is the centripetal acceleration of fluid around the particle. The force is opposite to FC and proportional to Uf2.
- (v) Added mass force FA—If Uf≠Up, the centripetal acceleration or deceleration of particles must displace some volume of surrounding fluid as it moves through it, since the object and fluid cannot occupy the same physical space simultaneously. The particle can thus be considered to have an added mass. This added mass subjects the particles to an additional force since the particle and surrounding fluid are under different centrifugal velocity. This force points towards the outer side of the channel i.e., opposite to the z-axis, given by
- (vi) Basset history force FH—The Basset force describes the force due to the lagging boundary layer development with changing relative velocity (acceleration) of bodies moving through a fluid. It is difficult to calculate accurately and is commonly neglected for practical reasons.
- (vii) Gravitational force FG—Gravity is at least one order smaller than centrifugal force in this case. It can be neglected here.
The resultant force acting on the particle in the yz plane (cross-section of the channel), neglecting the smaller terms (FG, FH),
If one assumes ρp=ρf=ρ, then one has
The resultant force FABC is pointing to the center of the channel curvature, and the magnitude is proportional to UfUs, i.e. proportional to Um2. It is one or two order smaller than FDD, as shown in
For a trapezoidal channel with a higher outer wall, there are many factors affecting the focusing position and separation efficiency, such as the width, inner and outer depth of the channel cross-section, the radius of the spiral curvature, and the slant angle. As analyzed above, the slant of the channel affects the focusing behavior in two ways: (i) at lower inner side, the increase of channel depth breaks the balance of the lift and drag force at high flow rate resulting in particle migration to the outer side and trapped at the vortex core, i.e., determines the threshold flow rate; and (ii) the location of the Dean vortex core. A large slant angle will lead to strong Dean at the outer side and increase trapping capability of particle. A large slant angle can also decrease the flow rate to drag out particles from the inner side. Particles will switch to the outer side at lower flow rate for a large slant angle channel, which is confirmed by experimental observation shown in
As another validation of this understanding, three different channel cross-section geometries were fabricated and tested (see
For a concave slant channel (shown in
The enumeration and characterization of circulating tumor cells (CTCs), found in the peripheral blood of cancer patients, provide a potentially accessible source for cancer diagnosis and prognosis. A spiral microfluidic device with trapezoidal cross-section is described herein for ultra-fast, label-free enrichment of CTCs from clinically relevant blood volumes. The technique utilizes the inherent Dean vortex flows present in curvilinear microchannels under continuous flow, along with inertial lift forces which focus larger CTCs against the inner wall. Using a trapezoidal cross-section as opposed to a traditional rectangular cross-section, the position of the Dean vortex core can be altered to achieve separation. Smaller hematologic components are trapped in the Dean vortices skewed towards the outer channel walls and eventually removed at the outer outlet, while the larger CTCs equilibrate near the inner channel wall and are collected from the inner outlet. Using a single spiral microchannel with one inlet and two outlets, more than 80% of cancer cell line cells (MCF-7, T24 and MDA-MB-231) spiked in 7.5 mL of blood were successfully isolated and recovered within 8 min with extremely high purity (400-680 WBCs/mL; about 4 log depletion of WBCs). Putative CTCs were detected and isolated from 100% patient samples (n=10) with advanced stage metastatic breast and lung cancer using standard biomarkers (CK, CD45 and DAPI) with frequency ranging from 3-125 CTCs/mL. This approach can surmount the shortcomings of traditional affinity-based CTC isolation techniques as well as enable fundamental studies on CTCs to guide treatment and enhance patient care.
In contrast to rectangular cross-section channels that typically use a sheath flow originating from a separate inlet to pinch the sample at the inlet to confine the sample to a narrow region across the channel width, so that all the cells start to migrate from approximately the same location, and thereby improve particle dispersion inside the channels when the particle concentration is high, the trapezoidal channels only need a single inlet for the sample, in which the sample can be introduced, e.g., using a single syringe pump, and two outlets for waste and enriched cell collection, respectively, during operation. In some aspects, the sample can be introduced using a piston pump, a gear pump, a peristaltic pump, a piezoelectric micropump, or using a controllable pressure regulator. Using a microfluidic device with this newly designed microchannel, enrichment of a high number of CTCs (3-125 CTCs/mL) from peripheral blood of patients with metastatic breast and lung cancer has been demonstrated. This device can process 7.5 mL of red blood cell lysed blood in about 8 min, allowing enrichment of viable CTCs with relatively high purity and yield. The trapezoidal spiral channels can be produced at extremely low-cost and with high resolution using conventional micro-milling and PDMS casting, and can be operated using a single syringe pump, which facilitates easy automation. This strategy can be utilized for large-scale processing of clinical samples in order to enrich sufficient amount of CTCs for various detailed molecular analyses as well as clinical monitoring of individual patients undergoing therapy. The device is well suited to process even larger quantities of blood if required (20 mL in about 15 min), to satisfy a growing need for obtaining large number of CTCs for multiple downstream tests.Material and Methods Device Design and Fabrication
The device design consists of an 8-loop spiral microchannel with one inlet and two outlets with radius increasing from 8 mm to 24 mm for efficient cell migration and focusing. The width of the channel cross-section is 600 μm and the inner and outer heights were optimized at 80 μm and 130 μm, respectively, for the trapezoid cross-section. The mold with specific channel dimensions was designed using SolidWorks software and then fabricated by conventional micro-milling technique (Whits Technologies, Singapore) on polymethyl methacrylate (PMMA) sheet for subsequent PDMS casting. The microfluidic device was fabricated by casting degassed PDMS (mixed in a 10:1 ratio of base and curing agent, Sylgard 184, Dow Corning Inc.) on the mold and subsequent baking inside an oven for 2 hours at 70° C. After curing, the PDMS was peeled from the mold and access holes (1.5 mm) for fluidic inlet and outlets were punched with a Uni-Core™ Puncher (Sigma-Aldrich Co. LLC. SG) and the PDMS devices were irreversibly bonded to another layer of cured PDMS using an oxygen plasma machine (Harrick Plasma, USA) to complete the channels. The assembled device was finally placed inside an oven at 70° C. for 30 minutes to further enhance the bonding.Cell Culture and Sample Preparation
Two commercially available green fluorescent protein (GFP)-tagged human cancer cell lines, namely breast adenocarcinoma (MCF-7 and MDA-MB-231), one bladder (T24; HTB-4 ATCC, USA) and one lung (H159; HTB-4 ATCC, USA) were used to mimic CTC separation. SKBR3 cell line was also employed as a control for DNA FISH analysis of HER2 in enriched CTCs. The aforementioned cells have an average diameter in a range of between about 10 μm and about 50 μm. The cells were seeded into coated T25 flasks (Becton, Dickinson and Company, Franklin Lakes, N.J., USA) and cultured with high-glucose Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, USA) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, USA) and 1% penicillin-streptomycin (Invitrogen, USA). The culture was kept in a humidified atmosphere at 37° C. containing 5% (v/v) CO2 and harvested at 80% confluence for spiking. Sub-confluent monolayers were dissociated using 0.01% trypsin and 5.3 mM EDTA solution (Lonza, Switzerland). For all experiments unless otherwise mentioned, whole blood obtained from healthy donors and patient samples were lysed with RBC lysis buffer (G-Bioscience, USA) for 5 minutes at room temperature with continuous mixing. Lysis was stopped by dilution with PBS buffer and cell pellet was obtained under centrifugation at 1000 g for 5 min. The cell pellet was resuspended to desired concentrations with PBS.Device Characterization
In all the experiments, the spiral biochip was initially mounted on an inverted phase contrast microscope (Olympus IX71) equipped with a high speed CCD camera (Phantom v9, Vision Research Inc., USA). The biochip was primed with a priming buffer (1× PBS, 2 mM EDTA supplemented with 0.5% BSA) using a syringe pump (PHD 2000, Harvard Apparatus, USA) for around 2 minutes at a flow rate of 2 mL/min. During testing, cancer cells and blood sample were filled in a 10 mL syringe and pumped through the device using a syringe pump connected to the microchannel through flexible Tygon® tubing. The flow rate was set to 1700 μL/min for all the experiments. High speed videos were captured at the channel outlet using the Phantom Camera Control software and then analyzed using ImageJ® software.Immunofluorescence Staining
To calculate the separation efficiency and enrichment ratio between the sample and sorted CTCs, flow cytometry using a BD Accuri™ C6 Flow Cytometer was employed for both the inlet and the CTC outlet. Immunofluorescence staining based on common markers for cancer cells and white blood cells (WBCs) was used for differentiation and quantification. The enriched cells from the CTC outlet were stained for fluorescein isothiocyanate (FITC) conjugated pan-cytokeratin (CK) (1:100, MiltenyiBiotec Asia Pacific, Singapore) and allophycocyanin (APC) conjugated CD45 marker (1:100, MiltenyiBiotec Asia Pacific, Singapore) for 30 minutes to identify cancer cells and WBCs, respectively. For clinical samples, CTCs were identified by staining with FITC-conjugated pan-cytokeratin (CK) (1:100, MiltenyiBiotec Asia Pacific, Singapore). Cells staining positively for pan-CK and Hoechst (nuclei stain) and negatively for CD45 with characteristic morphology of cancer cells (i.e., high nucleus to cytoplasm ratio) are identified as CTCs. Cells staining positively for CD45 and Hoechst and negatively for pan-cytokeratin are identified as leukocytes.Cell Viability Assay (Using PI Staining and Culturing)
MDA-MB-231 and MCF-7 GFP-tagged cells mixed with blood from healthy donors were processed through the spiral microfluidics, and cell viability was assessed via trypan blue (or Propidium iodide (PI)) exclusion assay and through long-term re-culturing. Isolated CTCs were seeded onto polylysine-coated 2D cell culture substrates and cultured overnight as described. Cells were then stained with propidium iodide (PI) stain in situ. Cells were imaged and enumerated for PI positive staining to determine the percentage of cell viability after lysis and processing. The cell viability numbers were compared with cells obtained after lysis without spiral biochip processing.Clinical Samples
Human whole blood samples were obtained from healthy donors and metastatic lung and breast cancer patients. This study was approved by the institutional review board and local ethics committee according to a protocol permitted by the Institutional Review Board (IRB). A total of 10 blood samples from healthy donors were used as controls and 10 samples from lung and breast cancer patients were processed for CTC enumeration. Blood samples were collected in vacutainer tubes (Becton-Dickinson, Franklin Lakes, N.J., USA) containing EDTA anticoagulant and were processed within 2-4 h to prevent blood coagulation. For all the samples, 7.5 mL of whole blood was lysed initially using RBC lysis, buffer and re-suspended in PBS prior to processing on chip. As an alternative to lysing, the whole blood can also be diluted by a factor in a range of between 5 times and 10 times prior to processing on chip.Fluorescence In Situ Hybridization
Fluorescence in situ hybridization (FISH) was performed on SKBR3 (amplified HER2 signals) and MDA-MB-231 (non-amplified HER2 signal) cells lines as well as isolated CTCs according to the manufacturer's protocol. Cells were spun onto slides using a Cytospin centrifuge (Thermo Scientific, USA) at 600 rpm for 6 minutes. Slides were fixed in 4% PFA at room temperature for 10 minutes and dehydrated via ethanol series (80%, 90%, and 100%). For FISH analysis, slides were treated with RNase (4 mg/mL) (Sigma, USA) for 40 minutes at 37° C., washed with 1× PBS/0.2% Tween 20 (Sigma, USA) thrice and denatured with 70% formamide/2×SCC (saline sodium citrate, Path Vysion, Abbott, USA) for 10 minutes at 80° C. They were then quench dehydrated again via ice-cold ethanol series. HER2/neu (Abbott Laboratories, Illinois, USA) probes were directly applied to slides maintained at 42° C. Hybridization was continued at 42° C. under dark and humid conditions overnight. Slides were washed with 50% formamide/2×SSC and 2×SSC at 45° C. under shaking, counterstained with 4′,6-diamidino-2-phenylindoleImmunofluorescence for Assay Characterization
To characterize the phenotypic ratio of CTC cultures, cells were incubated with a variety of antibodies, including fluorescein isothiocyanate (FITC) conjugated pan-cytokeratin (CK) (1:100, Miltenyi Biotec Asia Pacific, Singapore), fluorescein isothiocyanate (FITC) conjugated CD44 (1:100, Miltenyi Biotec Asia Pacific, Singapore), allophycocyanin (APC) conjugated CD24 (1:100, Miltenyi Biotec Asia Pacific, Singapore), allophycocyanin (APC) conjugated CD45 marker (1:100, Miltenyi Biotec Asia Pacific, Singapore) and Hoechst (Invitrogen, USA). Staining could be done either by adding the staining reagents directly onto the assay or in cell suspension after trypsinization. Cells were incubated for 30 minutes on ice with permeabilization (0.1% Triton 100×, Thermo Scientific, USA) after fixation with 4% paraformaldehyde (PFA) (Sigma Aldrich, USA).Results and Discussion Design Principle
When particles flow within a spiral microchannel, neutrally buoyant particles under the influence of inertial lift forces arising from the parabolic nature of the laminar velocity profile migrate across the streamlines to an equilibrium position away from the channel center towards the channel walls. At the same time, they also experience a drag force introduced by Dean vortices along the Dean flow arising due to the curvilinear geometry. The combination of inertial and Dean forces reduces the equilibrium positions to a single position at the inner microchannel wall within the channel width, inducing a continuous inertial focusing. Since both forces are a function of particle size, particles of different sizes occupy distinct lateral positions near the channel wall and exhibit different degrees of focusing, allowing size-based separation. One major challenge of utilizing a spiral microchannel with rectangular cross-section is that spacing between equilibrium positions of particles with varying diameters is narrow. This can affect the separation resolution. As discussed above, modifying the channel cross-section into a trapezoidal geometry can significantly enhance the separation resolution. This is mainly due to the fact that the asymmetry of trapezoid cross-section influences the velocity profile and results in the formation of strong Dean vortex cores near the outer wall that has the larger channel depth, as shown in
An optimal technology for CTC isolation must aim to isolate the maximum number of viable cells with acceptable degree of purity (i.e., depending upon the contamination tolerance of downstream molecular assays) without relying on specific markers (e.g., EpCAM) with minimum sample processing steps. To increase the purity and minimize the cellular components passing through the spiral chip, a conventional chemical RBC lysis approach was utilized to boost the throughput of the system while maximizing the number of enriched CTCs. Although it has been reported that RBC lysis and density gradient centrifugation steps can lead to cell loss (10-30%), the experimental results showed that cell loss is less than 8% during the entire process. Furthermore, exposure to lysis buffer also did not alter the morphology and size of the cells, as shown in
Isolation Efficiency and Cell Viability using Cancer Cell Lines
Since CTCs are extremely rare in blood stream, it is crucial to isolate the maximum number of target cells in a blood sample for various downstream assays. For this purpose, three different cell lines (i.e., MCF-7, T24 and MDA-MB-231) were employed in this study to quantify the performance of the trapezoidal spiral biochip for CTC isolation and recovery. These cell lines were chosen to ascertain the versatility of the technique in the detection of CTCs. The aforementioned cells have an average diameter in a range of between about 10 μm and about 50 μm. The model system is constructed by spiking a known number of cells (about 500 cells) into 7.5 mL of blood obtained from healthy donors. After RBC lysing and resuspension to the optimized concentration (about 0.5×), the sample was passed through the spiral chip for ultra-fast enrichment of spiked cells. Following enrichment, cancer cells were identified by immunofluorescence staining by either enumerating under epi-fluorescence microscope or flow cytometry analysis with common surface markers (CK+/CD45−).
To validate the clinical utility of the trapezoidal spiral biochip, a 7.5 mL of blood sample was obtained from each of (i) 5 healthy individuals (control), (ii) 5 patients with metastatic breast cancer (MBC) and (iii) 5 patients with non-small cell lung cancer (NSCLC) (Table 1).
Presence of isolated CTCs was determined by immunostaining with Hoechst (DNA), FITC-pan-cytokeratin (CK) antibodies (cancer/epithelial biomarker), and APC-anti-CD45 antibodies (hematologic biomarker) (see
Enriched CTCs are highly heterogeneous as previously reported in various studies (see
Tumor cell heterogeneity in many different aspects has been apparent and widely reported previously. See A. A. Powell, A. H. Talasaz, H. Zhang, M. A. Coram, A. Reddy, G. Deng, M. L. Telli, R. H. Advani, R. W. Carlson and J. A. Mollick, PLoS One, 2012, 7, e33788. Herein, the variation of HER2 expression in CTCs isolated with the trapezoid chip is shown using samples from patients with HER2-tumors. Pantel et al. have shown that HER2 status in CTCs varies with respect to the primary tumor. See B. R. BAS Jaeger, U Andergassen, J K Neugebauer, C A Melcher, C Scholz, C Hagenbeck, K Schueller, R Lorenz, T Decker, G Heinrich, T Fehm, A Schneeweiss, W Lichtenegger, M W Beckmann, K Pantel, H L Sommer, K Friese, and W Janni, presented in part at the Thirty-Fifth Annual CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, Tex., 2012. Specifically, HER2+ CTCs may be observed in about 30% of samples obtained from HER2-origin. DNA fluorescence in-situ hybridization (FISH) was carried out to evaluate HER2 status in isolated CTCs. HER2 signals in isolated CTCs were compared against control breast cancer cell lines MDA-MB-231 (non-amplified HER2 signal) and SKBR3 (amplified HER2 signals) as shown in
The “Holy Grail” of cancer medicine is the establishment of personalized therapies, where treatments shift from fixed regimes to therapies tailored to individual patients' tumor conditions. Circulating tumor cells have been shown to be a good alternative to primary tumor biopsies, carrying similar genetic information. Detection of CTCs in the peripheral blood of cancer patients at different disease stages has shown promise as a prognostic marker for treatment efficacy and patient survival, indicating strong clinical relevance. However, systematic characterization of CTCs in vitro via downstream assays has been delayed by the lack of reliable and sensitive methods to detect and enrich these cells. Despite the rapid advancement in microfluidic technologies, the isolation of CTCs with high throughput, high purity and high cell viability remains elusive. The application of a novel microfluidic platform for ultra-fast enrichment of putative CTCs using inertial microfluidics in spiral microchannels with trapezoidal cross-section is demonstrated herein. This improved device achieved higher (blood) volume processing, and increased CTC capture efficiency and yield. In addition to the rapid blood processing speed of 1.7 mL/min, the simple yet efficient trapezoidal spiral channels greatly facilitate scaled-up device production, and will thus enable larger-scale clinical studies. As described above, the trapezoidal spiral biochip successfully isolated CTCs from 10 out of 10 (100%) patients with advanced stage metastatic breast and lung cancer (3-125 CTCs/mL) and allowed extensive heterogeneity studies via immunostaining and DNA FISH analysis. Viability of isolated CTCs was also retained after processing which will allow potential culture and expansion studies. The majority of isolated CTCs from peripheral blood of breast cancer patients are viable but non-proliferative after days in culture, suggesting the requirement of new therapeutic approaches that targets cells in dormancy. In addition, the continuous collection of CTCs facilitates coupling of the device with conventional 96-well plate or a membrane filter for subsequent downstream analysis such as immunostaining, qRT-PCR, FISH and sequencing.
The precision and recovery rates at low cell spiking levels given by the inertial microfluidic system were high. Because this approach does not require initial cell surface biomarker selection, it is suitable for use in different cancers of both epithelial and non-epithelial origin. CTCs are reported to be highly heterogeneous and variable in EpCAM and cytokeratin expression, biomarkers used for CTC enrichment in many microfluidic devices. The selection criteria of cell size will overcome this limitation and capture a wider proportion of CTCs. Cells with lower expression of specific cytokeratins will still be identified with immunostaining due to the use of pan-cytokeratin antibodies. The sensitivity of the system was analyzed by determining the recovery rate of GFP-tagged breast (MCF-7 and MDA-MB-231) and bladder (T24) cancer cell lines spiked into blood obtained from healthy volunteers at the concentration of 500 cells/7.5 mL of blood. General limitations of various model systems are as described by Ring et al. See A. Ring, I. E. Smith and M. Dowsett, Lancet Oncol., 2004, 5, 79-88. Capture efficiency of cancer cells was high, ranging from 80-90%. This variability can partly be attributed to the differences in cell size between cancer types. Nevertheless, the flexibility and simplicity of the system allows for maximum cell isolation from different cancer types by moderate alterations of the channel design. The results demonstrate the versatility of the system for enriching CTCs of different cancer types, thus acting as a potential tool for the continuous assessment of CTCs and reliable CTC count detection in patients. The system is further validated by clinical trials on 10 blood samples from advanced stage metastatic breast and lung cancer. CTCs are detected in 10/10 samples, which clearly demonstrated the sensitivity of the system. However, inter-patient variability is observed, a trend reported previously. See M. Cristofanilli, T. Budd, M. J. Ellis, A. Stopeck, J. Matera, M. C. Miller, J. M. Reuben, G. V. Doyle, J. Allard, L. W. M. M. Terstappen and D. F. Hayes, N. Engl. J. Med., 2004, 351, 781-791; W. J. Allard, J. Matera, M. C. Miller, M. Repollet, M. C. Connelly, C. Rao, A. G. J. Tibbe, J. W. Uhr and L. W. M. M. Terstappen, Clin. Cancer Res., 2004, 10, 6897. This variability does not reflect the analytic performance of the system; rather it depends on various factors such as the stage of the disease and patient conditions that may affect on the number of CTCs present in the blood.
The application of standard histopathology and immunostaining procedures are essential to the understanding of the role of CTCs in cancer metastasis and potential drug treatment. To date, very low CTC counts were isolated by commercial platforms, limiting these downstream procedures. Improvement of CTC isolation will facilitate the use of standardized procedures for characterization, such as cytological examination by Papanicolaou (PAP) stains and DNA FISH. CTCs isolated with the trapezoidal spiral biochip were treated by PAP stain and revealed high nuclear to cytoplasmic (N/C) ratio, which is characteristic of cancer cells. Some CTCs are HER2+ when treated by respective DNA FISH probes. The presence of HER2+ CTCs varies across samples and is also observed in samples derived from patients with HER2-tumors (2 out of 5). This supports previous finding that heterogeneity of HER2 status is evident in CTC as compared to the primary tumor. See S. Riethdorf, H. Fritsche; V. Mülller, T. Rau2, C. Schindlbeck, W. J. Brigitte Rack, C. Coith, K. Beck, F. Jänicke, S. Jackson, T. Gornet, M. Cristofanilli and K. Pantel, Clin. Cancer Res., 2007, 13, 920. Detection of HER2 amplification in CTCs may identify high-risk breast cancer patients who may benefit from HER2 associated therapeutic strategies. In conclusion, this study shows the examination of blood samples for CTCs with the inertial microfluidic system.
The relevant teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety.
While this invention has been particularly shown and described with references to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
1. A micro-fluidic device comprising that can preferentially generate at least one strong Dean vortex along the flow stream:
- i) at least one inlet;
- ii) a curvilinear microchannel having a trapezoidal cross section defined by a radially inner side, a radially outer side, a bottom side, and a top side, the cross section having a) the radially inner side and the radially outer side unequal in height, or b) the radially inner side equal in height to the radially outer side, and wherein the top side has at least two continuous straight sections, each unequal in width to the bottom side, resulting in the generation of at least one strong Dean vortex core; and
- iii) at least one outlet.
2. The micro-fluidic device of claim 1, wherein the cross section has (a) the height of the radially inner side larger than the height of the radially outer side, or (b) the height of the radially inner side is smaller than the height of the radially outer side, or (c) the top side includes at least one step forming a stepped profile, or (d) the top side includes at least one shallow region in between the radially inner side and the radially outer side.
3. The micro-fluidic device of claim 1, wherein the trapezoidal cross section is a right trapezoidal cross section.
4. The micro-fluidic device of claim 1, wherein the top side or bottom side of the trapezoidal cross section is curved.
5. The micro-fluidic device of claim 4, wherein curved section is convex or concave.
10. The micro-fluidic device of claim 1, wherein the radially inner side or radially outer side of the trapezoidal cross section has a height in a range of between about 20 microns and about 200 microns.
12. The micro-fluidic device of claim 1, wherein the top side or bottom side of the trapezoidal cross section has a width in a range of between about 100 microns and about 2000 microns.
14. The micro-fluidic device of claim 1, wherein the curvilinear microchannel is a spiral microchannel or a serpentine microchannel.
16. The micro-fluidic device of claim 1, wherein the curvilinear microchannel has a radius of curvature in a range of between about 2.5 mm and about 25 mm.
17. The micro-fluidic device of claim 1, wherein the curvilinear microchannel has a length in a range of between about 4 cm and about 100 cm.
20. A method of separating by size one or more particles from a mixture of particles suspended in a liquid media, comprising introducing the mixture into at least one inlet of a micro-fluidic device of claim 2(b), at a flow rate that isolates particles along portions of the cross-section of the microchannel based on particle size, wherein larger particles flow along the radially inner side of the microchannel to a first outlet and smaller particles flow along other portions of the microchannel to at least one other outlet, thereby size separating the particles from the mixture and optionally collecting size separated particles from the first outlet.
23. The method of claim 20, wherein the particles are cells or a mixture of cells.
24. The method of claim 23, wherein the cells are stem cells; the mixture of cells is a blood sample; the mixture of cells is a bone marrow sample; the mixture of cells are stem cells and hematologic cells; the mixture of cells are CTC's and hematologic cells; the mixture of cells are leukocytes and hematologic cells.
34. A method of concentrating cells from a mixture, comprising introducing the mixture into at least one inlet of the micro-fluidic device of claim 2(a), at a flow rate that isolates the cells along the radially inner side of the cross section of the microchannel and directs them to a first outlet, thereby concentrating the cells from the mixture and optionally collecting concentrated cells from the first outlet.
37. A method of filtering particulates from a mixture, comprising introducing a particulate containing mixture into at least one inlet of the micro-fluidic device of claim 2(a) at a flow rate that isolates particulates along the radially inner side of the cross section of the microchannel and directs them to a first outlet, thereby filtering the particulates from the mixture and optionally collecting isolated particulates from the first outlet.
38. The method of claim 37, wherein the mixture is water.
41. A method of distributing cells in a mixture, comprising introducing the mixture into at least one inlet of the micro-fluidic device of claim 2(c) at a flow rate that distributes cells along portions of the stepped profile, wherein cells do not impact the sides before, during, or after distribution to separate outlets, thereby distributing the cells in the mixture and optionally collecting distributed cells from the separate outlets.
44. A method of mixing cells in a liquid, comprising introducing a liquid and cells into at least one inlet of the micro-fluidic device of a micro-fluidic device of claim 2(d) at a flow rate that mixes cells along the microchannel and directs the mixture to a first outlet and optionally collecting the mixture from the first outlet.
Filed: Sep 20, 2013
Publication Date: Aug 27, 2015
Patent Grant number: 9789485
Inventors: Jongyoon Han (Cambridge, MA), Chao Yu Peter Chen (Singapore), Chong Jin Ong (Singapore), Guofeng Guan (Singapore), Ali Asgar Bhagat (Singapore), Lidan Wu (Cambridge, MA)
Application Number: 14/429,280